{"study_id": 81050, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and potential adverse effects of exogenous melatonin in humans and provide recommendations for its use in specific patient groups.", "results_summary": "Short-term melatonin use was found to be safe even in extreme doses, with only mild adverse effects reported. Long-term use also showed mild adverse effects comparable to placebo, though safety in children, adolescents, pregnant, and breastfeeding women requires further study.", "population_specificity": "General human population, with specific considerations for children, adolescents, pregnant, and breastfeeding women.", "effective_dosage": "Not specified", "study_duration": "Short-term and long-term use assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:26.406467+00:00"}
{"study_id": 81053, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether CPAP therapy could correct the disturbed circadian rhythm of plasma melatonin in patients with severe obstructive sleep apnea syndrome (OSAS).", "results_summary": "Melatonin values were disturbed in OSAS patients, with a loss of nocturnal increase, and this pattern was not corrected by CPAP therapy. The study did not demonstrate efficacy of CPAP in restoring melatonin rhythm.", "population_specificity": "Seventeen male patients with severe OSAS (apnea-hypopnea index >30/h), 12 of whom were hypertensive and treated with antihypertensive drugs.", "effective_dosage": "Not specified", "study_duration": "About 8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:27.080194+00:00"}
{"study_id": 81048, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore whether perinatal melatonin supplementation could serve as a reprogramming strategy to prevent developmental programming of hypertension.", "results_summary": "The study suggests that melatonin, along with other interventions like citrulline, can shift the nitric oxide-reactive oxygen species balance, offering protective effects against both genetic and developmentally programmed hypertension. The abstract highlights common pathways, such as Ephx2 gene expression, that melatonin may influence to mitigate hypertension risk.", "population_specificity": "Animal models and human mother-child cohorts (developmental programming context).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:27.346224+00:00"}
{"study_id": 81049, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore melatonin's potential role in bone metabolism, focusing on its effects on bone growth and osteoclast activity, possibly mediated by ubiquitin ligases or proteasome inhibition.", "results_summary": "Preclinical studies indicate melatonin stimulates bone growth and inhibits osteoclast activity, potentially through ubiquitin ligases SCF(B-TrCP) and Keap-Cul3-Rbx or proteasome inhibition. Clinical trials for melatonin in bone disease treatment, including multiple myeloma, are suggested.", "population_specificity": "Preclinical studies (no specific human population mentioned).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:28.020916+00:00"}
{"study_id": 81056, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review melatonin's protective effects during pregnancy and its role in fetal brain development.", "results_summary": "Melatonin is highly transferred to the fetus during pregnancy, playing a crucial role in brain formation and differentiation. Decreased melatonin levels in pregnancy disorders are linked to disrupted brain programming, while its antioxidant and neuroprotective effects show promise against fetal brain injury.", "population_specificity": "Pregnant individuals and fetal brain development.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:32.952951+00:00"}
{"study_id": 81055, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the protective effects of melatonin against fibrosis in various organs and its potential as a treatment.", "results_summary": "Melatonin was found to regulate all major phases of the fibrogenic response and reduce fibrosis levels in multiple organs, including the heart, liver, lung, and kidney. It also inhibited adhesions following surgical procedures.", "population_specificity": "Not specified (review of existing studies).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:33.318260+00:00"}
{"study_id": 81059, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the benefits of melatonin and other chronobiotics in preserving the temporal order of aged organisms, particularly in addressing circadian disruptions.", "results_summary": "The study suggests that melatonin, along with bright light and other interventions, may help minimize the consequences of circadian disruptions in aging organisms, improving health and fitness and preventing sleep disturbances. However, the abstract does not provide specific data on melatonin's efficacy.", "population_specificity": "Aging animals and humans", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:34.352687+00:00"}
{"study_id": 81057, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of melatoninergic pathways in glioma and their potential as a pharmaceutical target for treatment.", "results_summary": "The study suggests that melatoninergic pathways may act as a hub coordinating multiple changes in glioma, including oxidative stress, immune-inflammatory processes, and tryptophan metabolism, making them a potential therapeutic target.", "population_specificity": "Glioma patients (primary and secondary metastases).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:34.404155+00:00"}
{"study_id": 81061, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to discuss the effects, side effects, and mechanism of action of various drugs, including Melatonin, used in the treatment of ADHD.", "results_summary": "The abstract does not provide specific findings about Melatonin's effects, only mentioning it as one of the medications used in ADHD treatment.", "population_specificity": "Children with ADHD.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:34.447180+00:00"}
{"study_id": 81058, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether daily melatonin ingestion could reverse increased blood pressure and reduced robustness of circadian rhythms in elderly subjects.", "results_summary": "Melatonin reduced systolic and diastolic blood pressure levels, particularly between 3:00 and 8:00 AM, and stabilized circadian rhythms. The hypotensive effect was most pronounced in subjects with the highest baseline blood pressure.", "population_specificity": "97 normotensive and hypertensive elderly volunteers (63-91 years old) living in a veteran house.", "effective_dosage": "1.5 mg daily at 22:30 h.", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:34.602677+00:00"}
{"study_id": 81054, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether melatonin could protect rats and humans from smoke-induced vascular injury.", "results_summary": "Melatonin reduced markers of vascular injury (CD31, ICAM-1, VCAM-1, ET-1) and improved protective factors (eNOS, Nrf2, NQO-1, GCLC, HO-1) in rats. In humans, it lowered fibrinogen, free fatty acids, and vascular injury markers while increasing protective factors like Nrf2 and HO-1.", "population_specificity": "Male rats and human smokers (63 participants in a double-blind RCT).", "effective_dosage": "10 mg/kg intraperitoneally in rats; 3 mg/day orally in humans.", "study_duration": "Two weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:35.158252+00:00"}
{"study_id": 81060, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of cataract surgery on circadian rhythm regulation and compare the impact of blue light-filtering versus clear intraocular lenses (IOLs) on melatonin levels and sleep quality.", "results_summary": "Cataract surgery improved circadian rhythm regulation as measured by the Pittsburgh Sleep Quality Index (PSQI), but the clinical relevance was uncertain. No significant difference was found between blue light-filtering and clear IOLs in their effects on circadian rhythms.", "population_specificity": "Individuals undergoing cataract surgery (specific demographics not detailed in the abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:36.563739+00:00"}
{"study_id": 81062, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore sleep disturbances in older adults, including nonpharmacological and pharmacologic treatment strategies, with emphasis on side effects.", "results_summary": "The abstract does not provide specific findings about Melatonin's effects.", "population_specificity": "Older-age adults, including those with Alzheimer disease and Lewy Body Dementia.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:39.690392+00:00"}
{"study_id": 81063, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of melatonin combined with fluoxetine in treating mood, sleep, and appetite disorders in postmenopausal women.", "results_summary": "The study found that melatonin combined with fluoxetine significantly reduced insomnia severity and BMI, while also showing comparable reductions in anxiety and depression to fluoxetine alone. The melatonin group showed greater improvements in sleep and weight management compared to the placebo group.", "population_specificity": "Overweight postmenopausal women aged 54-65 with increased appetite (n=64).", "effective_dosage": "5 mg melatonin in the evening, daily.", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:41.748047+00:00"}
{"study_id": 81067, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the clinical characteristics, biological mechanisms, and treatment strategies for Non-24-hour sleep-wake rhythm disorder (N24SWD).", "results_summary": "The abstract discusses the disorder's characteristics and mechanisms but does not provide specific findings on Melatonin's effects.", "population_specificity": "Sighted patients with potential psychiatric disorders and totally blind individuals.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:42.461090+00:00"}
{"study_id": 81065, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the role of melatonin in facilitating sleep and circadian realignment for individuals with jet lag and shift work disorder.", "results_summary": "The abstract indicates melatonin is used to facilitate sleep and circadian realignment, suggesting it has a beneficial role in managing circadian rhythm sleep-wake disorders, though specific efficacy data is not detailed.", "population_specificity": "Individuals with jet lag disorder and shift work disorder.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:42.493918+00:00"}
{"study_id": 81066, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential usefulness of melatonin in treating irregular sleep-wake rhythm disorder.", "results_summary": "The abstract suggests melatonin may be useful for some patients with irregular sleep-wake rhythm disorder, but does not provide specific efficacy data or statistical outcomes.", "population_specificity": "Individuals with irregular sleep-wake rhythm disorder, including children with neurodevelopmental disorders, psychiatric patients, and older adults with neurodegenerative disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:42.857445+00:00"}
{"study_id": 81068, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate how melatonin and melatonin receptor agonists can be used to shift circadian timing in patients with misaligned circadian rhythms.", "results_summary": "The abstract highlights that melatonin and other melatonin receptor agonists, along with light treatment, can effectively shift circadian timing in patients with misaligned rhythms, though specific efficacy details are not provided. Practical aspects of treatment are discussed, but concrete results are summarized rather than detailed.", "population_specificity": "Patients with misaligned circadian rhythms.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:43.116412+00:00"}
{"study_id": 81064, "supplement_id": 1328, "safety_score": "95", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effectiveness of melatonin supplementation for improving sleep disturbance and disease severity in children with atopic dermatitis (AD).", "results_summary": "Melatonin treatment significantly reduced the SCORAD index (indicating improved AD severity) by 9.1 points and shortened sleep-onset latency by 21.4 minutes compared to placebo. No adverse events were reported, and the intervention was deemed safe.", "population_specificity": "Children and adolescents aged 1 to 18 years with physician-diagnosed AD involving at least 5% of the total body surface area.", "effective_dosage": "3 mg/d", "study_duration": "4 weeks per treatment phase, with a 2-week washout period between phases.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:43.353422+00:00"}
{"study_id": 81069, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of melatonin in reducing complications during human pregnancy and the perinatal period, particularly in conditions like preeclampsia, IUGR, and perinatal asphyxia.", "results_summary": "Melatonin levels were altered in women with placental dysfunction during preeclampsia and IUGR. Short-term melatonin therapy was found to be highly effective and safe in reducing complications during pregnancy and the perinatal period, with potential neuroprotective benefits in perinatal asphyxia.", "population_specificity": "Pregnant women and neonates, particularly those with preeclampsia, IUGR, or perinatal asphyxia.", "effective_dosage": "Not specified", "study_duration": "Short-term (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:45.811997+00:00"}
{"study_id": 81070, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "To investigate the impact of multicomponent, nonpharmacologic interventions (MNI) on perioperative melatonin levels and postoperative delirium in elderly oral cancer patients.", "results_summary": "MNI increased nocturnal melatonin sulfate levels, reduced cortisol concentrations, improved postoperative recovery scores, and decreased the incidence and duration of postoperative delirium compared to usual care.", "population_specificity": "Elderly oral cancer patients undergoing tumor resection surgery.", "effective_dosage": "Not specified", "study_duration": "Perioperative period (day before surgery and first three postoperative days)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:46.922888+00:00"}
{"study_id": 81071, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential synergistic effects of buspirone and melatonin in promoting neurogenesis for treating depression and cognitive impairment.", "results_summary": "The study suggests that buspirone and melatonin may work synergistically to promote neurogenesis, supporting their combined use for depression and cognitive impairment, though additional effectiveness studies are warranted.", "population_specificity": "Older adult patients with dementia, pediatric patients, and individuals with depression or cognitive impairment.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:49.088163+00:00"}
{"study_id": 81072, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the impact of genetic variants on drug response and the potential for personalized sleep-wake therapies, including melatonin.", "results_summary": "The abstract highlights melatonin as an important neuromodulator in sleep-wake regulation but does not provide specific findings on its efficacy or safety. It emphasizes the need for pharmacogenomic investigations to optimize sleep-wake therapies.", "population_specificity": "Genetically engineered animal models, healthy volunteers, and sleep-disordered patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:49.674828+00:00"}
{"study_id": 81073, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the pharmacological properties of melatonin and synthetic ligands, focusing on their therapeutic effects mediated through MT1 and MT2 receptor activation.", "results_summary": "Melatonin and synthetic agonists (e.g., Circadin\u00ae, agomelatine, ramelteon, tasimelteon) show beneficial effects in sleep, circadian rhythm regulation, mood disorders, neuroprotection, and cancer. Selective targeting of MT1 or MT2 receptors may lead to more effective treatments.", "population_specificity": "Not specified (general review of pharmacological properties).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:50.042343+00:00"}
{"study_id": 81075, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize melatonin's beneficial effects on neural stem cells (NSCs) and discuss its potential therapeutic use for CNS neurodegenerative diseases.", "results_summary": "The study found that melatonin plays a significant role in NSC proliferation, differentiation, and survival, modulated by various pathways and factors. It suggests melatonin and its derivatives could be promising for treating neurodegenerative diseases.", "population_specificity": "Preclinical and translational studies (not human-specific).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:50.070882+00:00"}
{"study_id": 81074, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the pharmacokinetics of alternative administration routes of melatonin (excluding oral and intravenous) to assess absorption rates and bioavailability.", "results_summary": "Intranasal administration showed quick absorption and high bioavailability, transdermal had variable absorption with potential skin deposition, oral transmucosal achieved higher plasma concentrations than oral, and subcutaneous injection had rapid absorption but no clear advantages over other routes.", "population_specificity": "Not specified (in vivo studies, but human or animal not detailed in abstract).", "effective_dosage": "Not available.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:50.533569+00:00"}
{"study_id": 81076, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review melatonin's clinical applications, focusing on its potential as a therapeutic for CNS disorders, particularly stroke, and to explore natural melatonin treatment alternatives.", "results_summary": "The study highlights melatonin's role as an effective free radical scavenger and antioxidant, with potential therapeutic applications in stroke. It identifies three main treatment approaches (exogenous melatonin, pineal gland grafting, and melatonin-mediated stem cell therapy) and notes the need for further safety research.", "population_specificity": "Not specified (review of existing studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:51.075471+00:00"}
{"study_id": 81077, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate melatonin's potential as a protective agent against UV radiation-induced skin damage and immune suppression.", "results_summary": "The study highlights melatonin's antioxidative properties, its ability to attenuate apoptosis, and the efficacy of its metabolites in detoxifying free radicals, suggesting it could mitigate UVR-mediated damage, though further research is needed for clinical application.", "population_specificity": "Not specified (general focus on UV radiation effects on skin and immunity)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:54.345871+00:00"}
{"study_id": 81078, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the therapeutic efficacy of melatonin as an adjuvant therapy in treating neonatal sepsis.", "results_summary": "The study found that melatonin, when used alongside antibiotics, significantly improved sepsis scores compared to antibiotics alone at 24, 48, and 72 hours. Both groups showed improvement, but the melatonin group demonstrated greater clinical and laboratory outcomes.", "population_specificity": "50 infants diagnosed with neonatal sepsis.", "effective_dosage": "Single oral dose of 20 mg melatonin.", "study_duration": "72 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:54.517325+00:00"}
{"study_id": 81079, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to explore melatonin pathways as potential targets for new drug development in bipolar disorder.", "results_summary": "The abstract suggests melatonin pathways are being investigated as potential anchors for new agents in bipolar disorder, but efficacy data is limited and further research is needed.", "population_specificity": "Individuals with bipolar disorder, particularly treatment-resistant cases.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:56.430392+00:00"}
{"study_id": 81082, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate melatonin's efficacy in reducing chronic benzodiazepine (BZP) and Z drug use in insomnia patients and its safety profile.", "results_summary": "Melatonin demonstrated efficacy in reducing BZP consumption in elderly patients and promoting sleep, with a very safe profile and no potential for abuse, even at high doses and over long periods.", "population_specificity": "Elderly patients with insomnia and chronic BZP/Z drug use.", "effective_dosage": "Not specified (some studies used very large doses).", "study_duration": "Long periods (exact duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:57.306570+00:00"}
{"study_id": 81081, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore melatonin's protective mechanisms, particularly its inhibition of quinone reductase 2 (QR2), and how this might explain its broad protective effects against oxidative stress-related diseases.", "results_summary": "The study collated 300 cases of melatonin-induced protection, suggesting that at high concentrations (500 \u00b5M and beyond), melatonin inhibits QR2, potentially reducing harmful radical oxygen species linked to diseases like inflammation. This mechanism could unify various reported protective effects of melatonin.", "population_specificity": "Not specified (review of existing cases and experimental results)", "effective_dosage": "500 \u00b5M and beyond (pharmacological concentrations)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:57.826195+00:00"}
{"study_id": 81084, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore changes in melatonin levels as part of a broader study on the effects of Guided Imagery and Music (GIM) therapy on work-related stress.", "results_summary": "The abstract does not report specific findings related to melatonin's effects, only mentioning that changes in melatonin were explored alongside cortisol and testosterone.", "population_specificity": "Twenty Danish workers on sick leave due to work-related stress.", "effective_dosage": "Not specified", "study_duration": "Nine weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:57.864815+00:00"}
{"study_id": 81083, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety of melatonin in postmenopausal women with osteopenia, specifically its effects on balance, muscle function, and sleep quality.", "results_summary": "Melatonin did not affect postural balance, muscle strength, or risk of falls compared to placebo. A trend toward improved sleep quality was observed in women with baseline sleep disturbances, but no significant effects were seen in overall quality of life or sleep.", "population_specificity": "Postmenopausal women with osteopenia (n=81).", "effective_dosage": "1 mg or 3 mg nightly.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:59.155423+00:00"}
{"study_id": 81080, "supplement_id": 1328, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to assess the safety and efficacy of tasimelteon, a dual-melatonin receptor agonist, in entraining and maintaining circadian rhythms in totally blind individuals with non-24-hour sleep-wake disorder.", "results_summary": "Tasimelteon significantly improved circadian entrainment compared to placebo (20% vs. 3% at month 1) and maintained entrainment in 90% of patients who continued treatment versus 20% who switched to placebo. Common side effects included headache, elevated liver enzymes, and nightmares, but discontinuation rates due to adverse events were low and comparable between groups.", "population_specificity": "Totally blind adults (18-75 years) with non-24-hour circadian rhythm disorder.", "effective_dosage": "20 mg once daily, taken 1 hour before target bedtime.", "study_duration": "26 weeks (SET trial), with additional follow-up in RESET trial.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:59.536058+00:00"}
{"study_id": 81087, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to identify neuroprotective molecules, including melatonin, that could offer potential treatments for neonatal hypoxic ischemic encephalopathy (HIE).", "results_summary": "The abstract highlights melatonin as a promising neuroprotective molecule for future HIE treatments, but specific results regarding its efficacy are not detailed.", "population_specificity": "Neonates with hypoxic ischemic encephalopathy (HIE).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:03.089942+00:00"}
{"study_id": 81085, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "To determine if 6 mg melatonin administered before bedtime perioperatively in breast cancer surgery patients improves sleep outcomes measured by actigraphy.", "results_summary": "Melatonin significantly increased sleep efficiency and reduced wake after sleep onset postoperatively but had no effect on other objective sleep outcomes or subjective sleep quality measures (VAS and KSS). Overall, sleep outcomes remained within normal ranges, with no pathological disturbances reported.", "population_specificity": "Breast cancer surgery patients.", "effective_dosage": "6 mg approximately 60 minutes before bedtime.", "study_duration": "From 3 nights preoperatively until at least one week postoperatively.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:03.121174+00:00"}
{"study_id": 81086, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to assess the safety and tolerability of tasimelteon, a melatonin receptor agonist, in treating Non-24-hour Sleep-Wake Disorder (Non-24) and primary insomnia.", "results_summary": "Long-term tasimelteon administration was found to be safe and well-tolerated, with adverse events such as headache, diarrhea, and somnolence reported but no clinically significant differences in safety assessments. The study supported its efficacy in both Non-24 and insomnia patients.", "population_specificity": "Blind individuals with Non-24 and patients with primary insomnia.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Median exposure >1 year for Non-24 patients; 4-26 weeks for insomnia patients.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:03.269935+00:00"}
{"study_id": 81089, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to review the causes, consequences, and treatment options for insomnia in children, including behavioral and pharmacological therapies.", "results_summary": "The abstract does not provide specific findings about Melatonin's effects, only mentioning that pharmacological therapies are discussed.", "population_specificity": "Children, particularly those with autism spectrum disorders.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:04.285227+00:00"}
{"study_id": 81088, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review potential new therapeutic targets for preeclampsia, including substances that reduce oxidative stress, but did not specifically focus on Melatonin.", "results_summary": "The abstract does not provide specific findings about Melatonin's effects, as it broadly discusses potential therapeutic targets for preeclampsia without detailing any particular substance.", "population_specificity": "Pregnant women with or at risk of preeclampsia.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:05.699168+00:00"}
{"study_id": 81090, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate how melatonin inhibits estrogen-stimulated human breast cancer cells and explore its potential mechanism involving the ubiquitin-proteasome system.", "results_summary": "Melatonin demonstrated antiproliferative effects on estrogen-stimulated MCF-7 breast cancer cells, dependent on ER\u03b1 presence and dose. The study proposed a model where melatonin's inhibitory action is mediated by the ubiquitin-proteasome system, affecting ER\u03b1, apoptotic proteins, and cell cycle proteins.", "population_specificity": "Human MCF-7 breast cancer cell line (in vitro study).", "effective_dosage": "Dose-dependent (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:05.731233+00:00"}
{"study_id": 81092, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of melatonin on body composition, lipid metabolism, and glucose metabolism in postmenopausal women.", "results_summary": "Melatonin treatment reduced fat mass by 6.9% and showed a borderline significant increase in lean mass (5.2%) and adiponectin levels (21%). No significant changes were observed for leptin, insulin, or glucose homeostasis markers.", "population_specificity": "Postmenopausal women (n=81)", "effective_dosage": "1 or 3 mg nightly", "study_duration": "1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:06.610779+00:00"}
{"study_id": 81091, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether melatonin administration could modulate circadian rhythms and improve sleep efficiency in athletes with phase-shifted melatonin rhythms.", "results_summary": "Melatonin treatment induced a phase advance in wrist temperature rhythm, reduced nocturnal activity, and improved sleep efficiency compared to placebo, aligning circadian rhythms with athletes' chronotypes.", "population_specificity": "Athletes with delayed melatonin circadian rhythms", "effective_dosage": "100 mg/day, 30 minutes before bedtime", "study_duration": "Four weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:07.388856+00:00"}
{"study_id": 81095, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential benefits of melatoninergic drugs in treating comorbid psychiatric and neurological symptoms in epilepsy, beyond sleep-wake cycle regulation.", "results_summary": "The study highlights emerging evidence of melatonin's beneficial role in anxiety, depression, and epilepsy, suggesting its potential effectiveness for comorbid behavioral complications in epilepsy. However, clinical studies on this specific application remain limited.", "population_specificity": "Psychiatric and neurologic disorder patients, including those with anxiety, depression, and epilepsy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:11.080138+00:00"}
{"study_id": 81094, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate melatonin's role in insulin secretion, its circadian influence on pancreatic islets, and its potential implications in diabetes.", "results_summary": "Melatonin decreases insulin secretion by inhibiting cAMP and cGMP pathways but activates the phospholipaseC/IP3 pathway, increasing insulin secretion. It may contribute to diabetes due to reduced levels in diabetic patients and can restore glucose intolerance and insulin resistance caused by circadian disturbances.", "population_specificity": "Diabetic patients and pancreatic islets (in vitro and in vivo).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:11.363735+00:00"}
{"study_id": 81093, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to describe the pharmacokinetics of enteral melatonin in critically ill patients using a novel dosing regimen to simulate endogenous release.", "results_summary": "Melatonin administration (3 mg loading dose followed by 0.5 mg hourly doses) resulted in supra-physiological and sustained serum concentrations, with higher levels than placebo and previously reported endogenous concentrations in non-critically ill patients. The regimen demonstrated good oral bioavailability.", "population_specificity": "Critically ill patients in the recovery phase.", "effective_dosage": "3 mg loading dose at 9 pm, followed by six 0.5 mg doses hourly.", "study_duration": "12 hours overnight.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:11.990027+00:00"}
{"study_id": 81097, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to summarize melatonin's physiological and therapeutic effects, particularly its potential against parasites, bacteria, and viruses.", "results_summary": "Melatonin demonstrated therapeutic potential against various parasites (e.g., Plasmodium, Toxoplasma gondii, Trypanosoma cruzi) and showed in vitro activity against Leishmania infantum promastigotes, with mechanisms involving calcium modulation and immune system effects. It also exhibited effects in bacterial and viral infections, suggesting a promising strategy for disease control.", "population_specificity": "Not specified (broadly covers animals, plants, and microbes).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:12.600111+00:00"}
{"study_id": 81099, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore melatonin's role in protecting the nervous system from oxidative damage and inflammation, particularly in neural diseases.", "results_summary": "Melatonin was found to safeguard neuronal cells through antioxidants and other beneficial factors, suggesting its potential as a multi-action therapy for neural injury. The study highlights the need for multi-target approaches in treating neural damage.", "population_specificity": "Neural tissues and general neural injury contexts (not specified for humans or animals).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:13.308680+00:00"}
{"study_id": 81098, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the effects of circadian-rhythm-restoring interventions, including melatonin, on medical outcomes in critically ill patients.", "results_summary": "The study found that melatonin agonists improved rates of delirium, enhanced sleep, and reduced arrhythmia prevalence in critically ill patients. Observational and intervention studies suggested that circadian-rhythm-restoring factors, including melatonin, supported recovery.", "population_specificity": "Critically ill patients with disrupted circadian rhythms.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:14.550974+00:00"}
{"study_id": 81100, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to assess the long-term effects of melatonin on nocturnal sleep disturbances in Alzheimer's disease patients and its impact on caregiver stress.", "results_summary": "The study did not provide detailed results for melatonin's efficacy, but it was one of the treatments tested alongside risperidone and zolpidem. The abstract highlights risperidone as the most effective treatment, with no specific outcomes reported for melatonin.", "population_specificity": "93 mild-moderate Alzheimer's disease patients with sleep disturbances, including a subgroup of 9 treated with melatonin.", "effective_dosage": "2.55 mg melatonin (frequency not specified).", "study_duration": "5 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:15.187034+00:00"}
{"study_id": 81101, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess melatonin's effects on circadian biomarkers, sleep, and quality of life in breast cancer patients.", "results_summary": "Melatonin improved objective sleep quality, sleep fragmentation, subjective sleep, fatigue severity, global quality of life, and social and cognitive functioning. It also increased morning clock gene expression but did not affect circadian rhythmicity or cortisol patterns.", "population_specificity": "Thirty-two patients with metastatic breast cancer receiving hormonal or trastuzumab therapy.", "effective_dosage": "5 mg at bedtime", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:15.508440+00:00"}
{"study_id": 81102, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential of melatonin and other antioxidants in reducing oxidative stress and its impact on endometriosis.", "results_summary": "The study reported a significant effect of melatonin on endometriosis, suggesting its potential as a treatment by reducing oxidative stress. However, most evidence comes from in vitro or animal studies, necessitating further human trials.", "population_specificity": "Women with endometriosis (primarily in vitro or animal models, with limited human data).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:18.420048+00:00"}
{"study_id": 81104, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to determine the role of melatonin in the regulation of reproduction and maintenance of pregnancy in mammals, particularly its interaction with prolactin.", "results_summary": "The study found that melatonin levels increase during pregnancy, peaking at the end, suggesting its importance in pregnancy maintenance. It also highlighted that both melatonin and prolactin influence implantation and placental development.", "population_specificity": "Placental mammals (not human-specific).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:19.103986+00:00"}
{"study_id": 81103, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of exogenous melatonin in improving sleep quality in patients with neurodegenerative diseases, particularly Alzheimer's disease (AD) and Parkinson's disease (PD).", "results_summary": "Melatonin improved sleep quality in PD patients (measured by PSQI) and AD patients (measured by PSQI component 4), but not on objective sleep outcomes. It also effectively improved REM sleep behavior disorder (RBD) symptoms in elderly individuals with neurodegenerative disorders.", "population_specificity": "Patients with neurodegenerative diseases, specifically AD and PD, and elderly individuals with RBD.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:20.520433+00:00"}
{"study_id": 81105, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effect of cataract surgery on circadian photoentrainment and melatonin regulation, comparing blue-blocking and neutral intraocular lenses (IOLs).", "results_summary": "Cataract surgery increased photoreception by retinal ganglion cells, with a forward shift in circadian rhythm and increased peak salivary melatonin concentration. No significant differences were found between blue-blocking and neutral IOLs, and overall, surgery did not adversely affect circadian rhythm or sleep.", "population_specificity": "76 patients with bilateral age-related cataract eligible for cataract surgery.", "effective_dosage": "Not specified", "study_duration": "Measurements taken 2 days and 3 weeks after surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:20.976241+00:00"}
{"study_id": 81106, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine the efficacy of melatonin premedication in preventing emergence agitation in children recovering from general anesthesia.", "results_summary": "Melatonin premedication may be effective in preventing emergence agitation compared to placebo, but the evidence is of low certainty. High-dose melatonin showed potential efficacy compared to midazolam, but results were not statistically significant compared to dexmedetomidine.", "population_specificity": "Children undergoing general anesthesia.", "effective_dosage": "High-dose melatonin (specific amount not stated) was more effective than low-dose.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:21.041326+00:00"}
{"study_id": 81107, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to explore potential therapeutic approaches, including melatonin, for mitigating hypoxic responses and associated cardiovascular and pulmonary risks.", "results_summary": "The abstract suggests melatonin may serve as an antioxidant to counteract hypoxia-induced oxidative stress, but specific efficacy data or outcomes are not detailed.", "population_specificity": "Human populations exposed to high altitude, including permanent inhabitants, shift workers, tourists, and mountaineers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:21.550519+00:00"}
{"study_id": 81108, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review melatonin's effects on endoplasmic reticulum (ER) stress mechanisms, focusing on its regulation of autophagy and apoptosis in various pathologies.", "results_summary": "Melatonin modulates apoptosis and autophagy in cancer cells, neurodegeneration, and liver diseases, but further research is needed to clarify its mechanisms in ER stress responses.", "population_specificity": "Not specified (broad review of pathologies including metabolic, neurodegenerative, cardiovascular diseases, cancer, inflammation, and viral infections).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:23.084249+00:00"}
{"study_id": 81109, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the diverse biological and physiological roles of melatonin, including its effects on circadian rhythm, energy metabolism, and various organ systems, as well as its potential therapeutic applications.", "results_summary": "The study highlights melatonin's involvement in regulating multiple physiological functions, such as circadian rhythm, energy metabolism, and cardiovascular and neuropsychiatric systems, and notes its potential anti-neoplastic and anti-osteoarthritic effects. Recent research has also focused on its roles in oxidative stress, lipid metabolism, and hepatic steatosis.", "population_specificity": "Vertebrates (primarily synthesized by the pineal gland)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:24.366196+00:00"}
{"study_id": 81110, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether melatonin supplementation could prevent delirium in elderly patients, particularly comparing its effects in medical versus surgical wards.", "results_summary": "Melatonin showed a tendency to reduce delirium incidence overall (RR 0.41, P=0.08), with a significant 75% reduction in medical ward patients (RR 0.25, P=0.03), but no effect on sleep-wake rhythm or delirium in surgical wards.", "population_specificity": "Elderly patients (669 total) in medical and surgical wards.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:26.120128+00:00"}
{"study_id": 81111, "supplement_id": 1328, "safety_score": "80", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether oral melatonin at 20 mg could improve fatigue and other symptoms in patients with advanced cancer.", "results_summary": "The study found no significant differences between melatonin and placebo for physical fatigue or other symptoms, indicating melatonin did not improve fatigue in advanced cancer patients.", "population_specificity": "Patients aged \u226518 years with histologically confirmed stage IV cancer who reported significant fatigue.", "effective_dosage": "20 mg orally each night.", "study_duration": "1 week per treatment arm with a 2-day washout period.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:26.859787+00:00"}
{"study_id": 81114, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to analyze the interactions between melatonin, circadian rhythms, oxidative stress, and inflammatory processes in relation to central nervous system disorders.", "results_summary": "The study highlights melatonin's role as a natural antioxidant with circadian secretion patterns, linking its depletion to cell damage and disrupted circadian rhythms, which may contribute to neurodegenerative and psychiatric disorders. It suggests melatonin's antioxidant properties offer therapeutic potential for central nervous system disorders.", "population_specificity": "Not specified (review of existing studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:28.251504+00:00"}
{"study_id": 81113, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential usefulness of melatonin in mitigating circadian disruption and improving outcomes in critically ill ICU patients.", "results_summary": "The abstract suggests melatonin may help address circadian misalignment, sleep impairment, and delirium in ICU patients, though specific efficacy data is not detailed. Practical countermeasures, including melatonin treatment, are proposed to enhance circadian rhythmicity.", "population_specificity": "Critically ill patients in intensive care units (ICU)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:28.301615+00:00"}
{"study_id": 81112, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 85, "quality_score": 70, "study_goal": "To evaluate the efficacy and safety of melatonin for treating chronic central serous chorioretinopathy (CSCR).", "results_summary": "Melatonin significantly improved best-corrected visual acuity (BCVA) in 87.5% of treated patients and reduced central macular thickness (CMT) in all patients, with 37.5% achieving complete resolution of subretinal fluid. No significant side effects were observed, and the placebo group showed no changes.", "population_specificity": "13 patients with chronic CSCR and 20/40 or worse BCVA or incapacitating scotoma, most with prior failed treatments.", "effective_dosage": "3 mg melatonin t.i.d. (three times daily)", "study_duration": "1 month", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:29.402681+00:00"}
{"study_id": 81116, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review melatonin's molecular interactions with cellular targets and its potential therapeutic effects on tumor progression, neurodegeneration, and aging.", "results_summary": "Melatonin targets apoptosis, metastasis, angiogenesis, and inflammatory pathways, showing antagonist effects on genes linked to tumor progression, neurodegeneration, and aging. It also reduces toxicity from chemotherapeutic agents in advanced tumor stages.", "population_specificity": "Not specified (review of molecular and cellular interactions)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:30.526947+00:00"}
{"study_id": 81115, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine melatonin's potential as a therapy for IUGR pregnancies and its implications on sleep and cardiovascular development in infants.", "results_summary": "Animal studies suggest melatonin has neuroprotective and cardioprotective effects in IUGR fetuses, and clinical trials are underway to assess its short- and long-term effects in human pregnancies. The abstract highlights melatonin's role in sleep regulation and potential benefits for cardiovascular function in IUGR-affected infants.", "population_specificity": "Pregnancies complicated by intrauterine growth restriction (IUGR) and their developing infants.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:31.307172+00:00"}
{"study_id": 81117, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 30, "study_goal": "The researchers aimed to describe the clinical features of hypnic headache (HH) in childhood and evaluate treatment outcomes, including melatonin's effectiveness.", "results_summary": "Melatonin was successfully used to treat HH in 2 out of 5 pediatric patients (40%). The study noted inconsistent clinical features of HH in children, with limited data on melatonin's broader efficacy.", "population_specificity": "Children (ages 7-11) diagnosed with hypnic headache.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:32.440569+00:00"}
{"study_id": 81119, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not specifically address Melatonin; it focuses on sleep disturbances in traumatic brain injury (TBI) patients and general treatment approaches.", "results_summary": "The abstract does not report findings on Melatonin; it discusses sleep disturbances in TBI patients and general ICU treatment strategies.", "population_specificity": "Patients hospitalized for traumatic brain injury (TBI).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:34.226798+00:00"}
{"study_id": 81118, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether oral melatonin premedication could reduce anxiety and pain in children undergoing blood sample collection.", "results_summary": "Melatonin significantly reduced both pre-procedural anxiety and procedural pain compared to placebo, with strong statistical significance across different age groups. The effects were consistent, supporting its use for anxiolysis and analgesia in pediatric blood draws.", "population_specificity": "60 children aged 1-14 years, divided into two equal groups.", "effective_dosage": "0.5 mg/kg body weight (maximum 5 mg), administered orally 30 minutes before the procedure.", "study_duration": "Single administration before blood draw.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:34.687607+00:00"}
{"study_id": 81121, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the interactions between melatonin and adipokines (leptin and adiponectin) and assess melatonin's potential therapeutic effects on obesity and related disorders.", "results_summary": "Melatonin was found to normalize the expression and secretion patterns of leptin and adiponectin, supporting its role in improving obesity-related metabolic disturbances. Despite some inconsistencies, the study highlights melatonin's beneficial effects on obesity complications.", "population_specificity": "Not specified (general obesity-related disorders)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:36.331337+00:00"}
{"study_id": 81120, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the clinical and radiographic effects of locally applied melatonin gel on the stability and bone resorption of immediately loaded dental implants in low bone density areas.", "results_summary": "The study found that melatonin application improved implant stability and reduced marginal bone resorption at 1 and 3 months compared to the control group, with all implants remaining successful after 12 months. However, longer follow-up studies were recommended to confirm melatonin's effects on osseointegration.", "population_specificity": "14 patients with missing maxillary premolars.", "effective_dosage": "Not specified (local application of melatonin gel at the osteotomy site).", "study_duration": "12 months (follow-up period).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:37.614382+00:00"}
{"study_id": 81122, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate disturbances in circadian rhythms, including melatonin levels, in hemodialysis patients compared to healthy controls.", "results_summary": "The study found reduced nocturnal melatonin concentrations in hemodialysis patients, along with impaired sleep quality and disrupted circadian rhythms of cortisol and clock gene expression. Hemodialysis patient serum also showed a higher capacity to synchronize cells in vitro, suggesting accumulation of clock-resetting compounds.", "population_specificity": "Hemodialysis patients (n=9) and healthy controls (n=9).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:38.095827+00:00"}
{"study_id": 81123, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential of melatonin, among other drugs, to mitigate weight gain or adverse metabolic effects associated with psychotropic medications.", "results_summary": "The study suggests melatonin has favorable effects on obesity or medication-related weight gain, making it appropriate for patients starting psychotropic drugs linked to metabolic issues. However, dedicated studies in psychiatric populations are needed for further validation.", "population_specificity": "Individuals with psychiatric illness, particularly those at risk of weight gain or metabolic effects from psychotropic drugs.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:38.665624+00:00"}
{"study_id": 81124, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of melatonin and melatonin agonists in treating sleep disorders and preventing relapses in patients with bipolar disorder (BD).", "results_summary": "The study found that melatonin and its agonists show promise as adjunctive treatments for sleep abnormalities in BD, potentially preventing relapses and improving metabolic syndrome in antipsychotic-treated patients. Melatonin was well-tolerated with minimal dependence risk.", "population_specificity": "Patients with bipolar disorder (BD), particularly those with sleep abnormalities or in remission phases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:39.127269+00:00"}
{"study_id": 81125, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to review melatonin's protective role against mitochondrial dysfunction in neurodegenerative diseases and explore its potential as a therapeutic tool.", "results_summary": "Melatonin was found to prevent oxidative stress-induced mitochondrial dysfunction in experimental models of neurodegenerative diseases like PD, AD, and HD, due to its unique antioxidant properties and selective uptake by mitochondrial membranes. The study highlights melatonin's potential as a safe and effective treatment for mitochondrial-related neurodegenerative disorders.", "population_specificity": "Experimental models (in vitro and in vivo) of neurodegenerative diseases (e.g., PD, AD, HD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:40.961708+00:00"}
{"study_id": 81127, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review recent studies on the efficacy and safety of melatonin in treating sleep problems in children with developmental disabilities.", "results_summary": "Short-term melatonin treatment significantly reduced sleep onset latency in most developmental disabilities, except tuberous sclerosis. Side effects were rare and mild.", "population_specificity": "Children with developmental disabilities", "effective_dosage": "Not specified", "study_duration": "Short-term (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:41.611780+00:00"}
{"study_id": 81126, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore strategies, including melatonin, to augment endogenous neuroprotection in neonatal encephalopathy following hypoxic-ischaemic insults.", "results_summary": "The abstract suggests melatonin is one of the interventions that can supplement the endogenous response to hypoxia-ischaemia to achieve full neuroprotective potential, alongside other therapies like therapeutic hypothermia and erythropoietin. However, specific results regarding melatonin's efficacy are not detailed.", "population_specificity": "Infants with neonatal encephalopathy following hypoxic-ischaemic insults.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:42.234096+00:00"}
{"study_id": 81128, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of Melatonin in treating sleep problems in children with ADHD.", "results_summary": "The study found that Melatonin is an effective treatment for sleep problems in children with ADHD, though it noted that stimulant treatment for ADHD may disrupt sleep.", "population_specificity": "Children with ADHD experiencing sleep problems.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:43.418144+00:00"}
{"study_id": 81130, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a combination of buspirone and melatonin-SR could improve cognitive function in MDD patients, independent of mood symptom relief.", "results_summary": "The combination treatment (buspirone with melatonin-SR) showed significant improvement in cognitive function compared to buspirone monotherapy or placebo, particularly among treatment non-responders. The cognitive dimension of the CPFQ favored the combination treatment, suggesting melatonin may target specific cognitive deficits in MDD.", "population_specificity": "Patients with Major Depressive Disorder (MDD) experiencing acute depressive episodes.", "effective_dosage": "Melatonin-SR 3 mg (combined with buspirone 15 mg).", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:47.048864+00:00"}
{"study_id": 81129, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate whether melatonin treatment could improve bone mass and integrity in postmenopausal osteopenic women.", "results_summary": "Melatonin increased femoral neck BMD in a dose-dependent manner (1.4% overall, 2.3% with 3 mg/day) and improved trabecular thickness in the tibia (2.2%) and spinal vBMD (3.6% with 3 mg/day). No significant effects were observed at other sites or on bone turnover markers, but 24-hour urinary calcium decreased by 12.2%.", "population_specificity": "Postmenopausal osteopenic women aged 56-73 years.", "effective_dosage": "1 mg/day and 3 mg/day, administered nightly.", "study_duration": "1 year.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:47.132706+00:00"}
{"study_id": 81131, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review studies on the pharmacokinetics of exogenous melatonin in humans and provide recommendations for clinical use.", "results_summary": "The review found that melatonin pharmacokinetics varied widely with dosage and administration route, with Tmax around 50 minutes for oral immediate-release formulations and T1/2 of 45 minutes. Bioavailability of oral melatonin was approximately 15%, and pharmacokinetics were influenced by factors like age, caffeine, smoking, and medications.", "population_specificity": "Humans, including critically ill patients.", "effective_dosage": "0.3 to 100 mg, administered orally or intravenously.", "study_duration": "Not specified.", "interactions": "Caffeine, smoking, oral contraceptives, feeding status, and fluvoxamine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:47.378753+00:00"}
{"study_id": 81133, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the role of melatonin in treating primary insomnia in menopausal women.", "results_summary": "Melatonin was identified as a preferential treatment option for primary insomnia in menopausal women, alongside non-benzodiazepine hypnotics and cognitive behavioral therapy. The abstract does not provide specific efficacy data for melatonin but positions it as a recommended therapeutic option.", "population_specificity": "Menopausal women with primary insomnia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:48.185741+00:00"}
{"study_id": 81134, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate melatonin's potential clinical role in neurodegenerative diseases, focusing on its antioxidative properties and neuroprotective mechanisms.", "results_summary": "Melatonin demonstrated significant antioxidative effects, including scavenging various radicals and stimulating antioxidative enzymes, suggesting potential benefits in neurodegenerative disorders like Alzheimer's and Parkinson's disease. However, larger, well-designed clinical trials are needed to confirm these findings.", "population_specificity": "Patients with neurodegenerative disorders (e.g., Alzheimer's, Parkinson's, ALS, multiple sclerosis).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:51.033695+00:00"}
{"study_id": 81135, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether nocturnal melatonin supplementation could reduce the need for sedation in critically ill patients with mechanical ventilation.", "results_summary": "Melatonin-treated patients required less enteral hydroxyzine and showed improvements in neurological indicators and reduced costs for neuroactive drugs, though ICU/hospital mortality and post-traumatic stress disorder prevalence were unaffected.", "population_specificity": "Critically ill patients with mechanical ventilation >48 hours and Simplified Acute Physiology Score II >32 points.", "effective_dosage": "3 mg at 8 p.m. and 3 mg at midnight.", "study_duration": "From the third ICU day until ICU discharge.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:51.880814+00:00"}
{"study_id": 81136, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of clear intraocular lenses (IOLs) versus blue-blocking IOLs on circadian rhythm-related outcomes, including urinary melatonin metabolite levels, in cataract patients.", "results_summary": "The study is ongoing, and no results regarding melatonin's effects have been reported yet. Primary and secondary outcomes, including urinary melatonin metabolite levels, will be assessed over a 20-year follow-up period.", "population_specificity": "1000 cataract patients", "effective_dosage": "Not specified", "study_duration": "Primary outcomes followed for 20 years; secondary outcomes assessed at baseline and 1 year post-surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:52.114142+00:00"}
{"study_id": 81138, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to assess the role of melatonin agonists in treating insomnia in alcohol-dependent adults, weighing their benefits and risks among other treatment options.", "results_summary": "The abstract mentions melatonin agonists as one of the treatment options for insomnia in alcohol-dependent patients, noting they have benefits and risks that must be weighed and monitored, but does not provide specific efficacy data for melatonin.", "population_specificity": "Alcohol-dependent adults with persistent insomnia despite 4 or more weeks of sobriety.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:54.964517+00:00"}
{"study_id": 81137, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the mechanisms of serotonin-induced immunomodulation and its relevance to diseases with inflammatory components, including the role of melatonin as a biologically active catabolite.", "results_summary": "The abstract mentions that melatonin is a biologically active catabolite generated from serotonin metabolism, but it does not provide specific findings on melatonin's effects. The focus is on serotonin's immunomodulatory role in various diseases.", "population_specificity": "Not specified (review covers diverse cell types and diseases with inflammatory components).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:55.098067+00:00"}
{"study_id": 81139, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore potential treatment options, including melatonin derivatives, for restoring normal sleep cycles in patients with traumatic brain injury (TBI)-related sleep disruption.", "results_summary": "The abstract suggests that melatonin derivatives may be a potential treatment for sleep disruption following TBI, but no specific efficacy data or results are provided regarding melatonin's effects.", "population_specificity": "Patients with traumatic brain injury (TBI) experiencing sleep disruption.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:55.113310+00:00"}
{"study_id": 81140, "supplement_id": 1328, "safety_score": "80", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the clinical properties, safety, and efficacy of ramelteon, a selective melatonin receptor agonist, for treating insomnia characterized by sleep onset difficulties.", "results_summary": "Ramelteon demonstrated sleep-promoting effects in clinical trials and practice without the adverse effects typical of other hypnotics, though its efficacy was modest compared to current insomnia therapeutics. Further studies are needed to assess its effects on sleep quality, maintenance, daytime function, and comorbid insomnia conditions.", "population_specificity": "Patients with insomnia characterized by sleep onset difficulties.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:56.823957+00:00"}
{"study_id": 81132, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the efficacy of melatonin in reducing chronic benzodiazepine (BZD)/Z-drug use in insomnia patients.", "results_summary": "The study suggests that melatonin can help restore the sleep-wake cycle by acting as a chronobiotic drug, potentially offering an alternative to BZD/Z-drugs, which are associated with tolerance, dependency, and reduced quality of life. However, the abstract does not provide specific efficacy data or statistical outcomes.", "population_specificity": "Insomnia patients, particularly those using BZD/Z-drugs.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:58.344527+00:00"}
{"study_id": 81141, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to review pharmacological and non-pharmacological treatments, including melatonin, for sleep disorders in elderly patients with Alzheimer dementia.", "results_summary": "The abstract mentions melatonin as one of the treatments reviewed but does not provide specific efficacy results for it. It highlights trazodone as effective, while noting more studies are needed for melatonin and other treatments.", "population_specificity": "Elderly patients with Alzheimer dementia in an ambulatory setting.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:58.802832+00:00"}
{"study_id": 81143, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of melatonin versus placebo on the occurrence of delirium in hip-fracture patients, as part of a broader study on perioperative QTc-duration changes.", "results_summary": "The abstract does not report specific results regarding melatonin's effects, as the focus was on QTc-duration changes and haloperidol use.", "population_specificity": "Elderly hip-fracture patients (mean age 84 years, 24% male).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:00.011611+00:00"}
{"study_id": 81142, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to provide an updated overview of melatonin's effects on male reproductive health and explore potential mechanisms of action.", "results_summary": "Melatonin's antioxidant properties were found to improve male reproductive dysfunctions linked to pathological conditions and toxicant exposure, though its exact molecular mechanisms remain unclear. The study highlights melatonin's low toxicity and ability to cross physiological barriers like the blood-testis barrier.", "population_specificity": "Male reproductive system (no specific human or animal population detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:01.002135+00:00"}
{"study_id": 81146, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "To examine the effect of dynamic light on staff's sleep quality, including melatonin levels in saliva, sleep efficiency, and subjective sleep perceptions.", "results_summary": "No significant differences were found in monitored sleep efficiency or melatonin levels between the intervention and control groups, but nurses in the intervention group subjectively felt more rested and assessed their condition upon awakening as better.", "population_specificity": "Nurses working in intensive care units (ICUs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:02.762053+00:00"}
{"study_id": 81145, "supplement_id": 1328, "safety_score": "80", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to explore melatonin's physiological functions, its role in circadian rhythm regulation, and potential therapeutic applications.", "results_summary": "Melatonin conveys light/dark cycle information to the body, stabilizes circadian rhythms (e.g., core temperature and sleep-wake cycles), and influences immune, antioxidant, and metabolic functions. Its therapeutic potential is noted, but efficacy and long-term safety require further large-scale trials.", "population_specificity": "Not specified (general discussion of human physiological functions).", "effective_dosage": "Not specified (mentions \"physiological\" dose matching nocturnal peak levels).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:03.729897+00:00"}
{"study_id": 81144, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine whether prolonged-release melatonin (2 mg) affects nocturnal sleep EEG power spectra differently compared to temazepam (20 mg) and zolpidem (10 mg) in middle-aged individuals.", "results_summary": "Prolonged-release melatonin had minor effects on EEG slow-wave activity (SWA) during sleep, reducing it only in the first third of the night, unlike temazepam and zolpidem, which significantly reduced SWA throughout the night. The study suggests melatonin's effects on sleep EEG are distinct due to its different mechanism of action.", "population_specificity": "16 healthy men and women aged 55-64 years.", "effective_dosage": "2 mg prolonged-release melatonin (single oral dose).", "study_duration": "Single-dose intervention (cross-over trial).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:04.608750+00:00"}
{"study_id": 81147, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential of melatonin and melatonin agonists in preventing delirium, particularly in medically unwell individuals.", "results_summary": "Melatonin and melatonin agonists show promise for delirium prevention due to their benign side effect profile, though the abstract notes inconsistent and conflicting data regarding the efficacy of pharmacological agents overall.", "population_specificity": "Older hospitalized patients, particularly those in surgical and acute illness settings.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:05.372272+00:00"}
{"study_id": 81149, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of earplugs, eye masks, and relaxing music on sleep, melatonin, and cortisol levels in ICU patients.", "results_summary": "The study found no significant differences in urinary melatonin levels between intervention and control groups, but melatonin levels were significantly lower post-surgery compared to pre-surgery. The intervention improved subjective sleep quality but did not influence melatonin or cortisol levels.", "population_specificity": "Adult ICU patients who underwent scheduled cardiac surgery.", "effective_dosage": "Not specified", "study_duration": "Two postoperative nights", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:06.836975+00:00"}
{"study_id": 81148, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of simulated ICU noise and light on nocturnal sleep quality and compare the effectiveness of melatonin versus earplugs and eye masks in improving sleep quality under these conditions.", "results_summary": "Melatonin (1 mg) significantly improved total sleep time, REM sleep, sleep onset latency, and perceived sleep quality compared to earplugs and eye masks, while also increasing serum melatonin levels. Both interventions reduced awakenings and anxiety, but melatonin showed superior results in subjective sleep quality.", "population_specificity": "Healthy subjects exposed to simulated ICU noise and light conditions.", "effective_dosage": "1 mg oral melatonin administered at 21:00.", "study_duration": "Four consecutive days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:07.652057+00:00"}
{"study_id": 81150, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to explore the effects of non-thermal microwave EMF exposure on biological systems, including melatonin disruption, via voltage-gated calcium channel activation.", "results_summary": "The study found that non-thermal EMF exposure leads to lowered melatonin levels and sleep disruption, among other downstream effects like oxidative stress and DNA damage, mediated by VGCC activation.", "population_specificity": "Not specified (general biological systems, including mammalian cell lines/cultures).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:07.733712+00:00"}
{"study_id": 81151, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to explore melatonin's effects on oxidative and inflammatory biomarkers in ischemia-reperfusion injuries and its potential clinical application in reducing such damage.", "results_summary": "Melatonin demonstrated antioxidant and anti-inflammatory properties in experimental studies, but human clinical trial results were pending. The porcine model outcomes were suboptimal, leaving melatonin's efficacy in large animal models unresolved.", "population_specificity": "Pigs (porcine model) and pending human clinical trial (AMI patients undergoing pPCI).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:08.812598+00:00"}
{"study_id": 81153, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the effect of melatonin on pre- and postoperative anxiety in adults compared to placebo or benzodiazepines.", "results_summary": "Melatonin reduced preoperative anxiety compared to placebo, with high-quality evidence, and showed similar efficacy to midazolam. Postoperative anxiety results were mixed, with some studies showing no difference and others indicating a reduction.", "population_specificity": "Adults (15 to 90 years) undergoing surgical procedures requiring general, regional, or topical anesthesia.", "effective_dosage": "Not specified", "study_duration": "Single preoperative administration", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:11.353384+00:00"}
{"study_id": 81154, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of combining melatonin with therapeutic hypothermia for neuroprotection in neonatal hypoxic-ischemic brain injury.", "results_summary": "The study found that combining melatonin with therapeutic hypothermia resulted in more favorable neurological outcomes compared to hypothermia alone. However, specific details on melatonin's efficacy, such as effect size or statistical significance, were not provided.", "population_specificity": "Neonates with hypoxic-ischemic brain injury.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:12.159586+00:00"}
{"study_id": 81155, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the duration of action of melatonin agonists (melatonin, 2-iodomelatonin, ramelteon, and ramelteon metabolite M-II) at the melatonin MT1 receptor and identify factors influencing their persistence.", "results_summary": "The study found significant differences in the duration of action among melatonin agonists, with ramelteon and 2-iodomelatonin showing persistent agonist activity even after washout, unlike melatonin and M-II. The duration of action correlated strongly with dissociation rates from the MT1 receptor but not with lipophilicity or desensitization extent.", "population_specificity": "Chinese hamster ovary cells stably expressing human melatonin MT1 receptor and INS-1 cells endogenously expressing rat MT1 receptor.", "effective_dosage": "Not specified", "study_duration": "2-hour pretreatment with agonists followed by washout", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:15.409368+00:00"}
{"study_id": 81157, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the genetic link between melatonin suppression due to artificial light at night (ALAN) and cancer risks, particularly breast cancer, focusing on epigenetic mechanisms.", "results_summary": "The study suggests that melatonin suppression by ALAN may contribute to cancer risks through epigenetic modifications, such as global hypomethylation in oncogenes and local hypermethylation in tumor suppressor genes. It highlights the potential reversibility of these modifications and the need for early detection biomarkers.", "population_specificity": "General population exposed to artificial light at night, with a focus on breast cancer incidence.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:15.616251+00:00"}
{"study_id": 81156, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the role of melatonin and its precursors in multiple sclerosis (MS), focusing on its potential as a treatment target due to its antioxidant, anti-inflammatory, and mitochondrial function-improving properties.", "results_summary": "The study suggests melatonin may improve mitochondrial function, inhibit demyelination, and promote remyelination in MS, with potential benefits for pain, inflammation, and depression. It highlights melatonin's local production in astrocytes and immune cells as a key factor in MS etiology and treatment.", "population_specificity": "Multiple sclerosis (MS) patients (theoretical focus, not a clinical trial).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:15.949842+00:00"}
{"study_id": 81159, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review melatonin's potential anti-gastrointestinal cancer effects, including its mechanisms, preventive role, and therapeutic synergy.", "results_summary": "Melatonin demonstrated substantial inhibitory effects on gastrointestinal cancer by reducing proliferation, invasion, metastasis, and angiogenesis while promoting apoptosis and cancer immunity. The study also highlighted melatonin's preventive role in carcinogenesis and its synergy with other drugs.", "population_specificity": "General discussion (epidemiologic surveys, animal, and human studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:16.680794+00:00"}
{"study_id": 81160, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate melatonin's potential as a safe and effective treatment for preventing and treating necrotizing enterocolitis in premature infants by counteracting oxidative stress.", "results_summary": "Melatonin demonstrated efficacy in counteracting oxidative injury in newborns, with no significant toxicity or treatment-related side effects reported in long-term use. It was considered a potentially safe adjunct to standard therapies for necrotizing enterocolitis.", "population_specificity": "Premature neonates, including cases of asphyxia, respiratory distress syndrome, and sepsis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:19.705336+00:00"}
{"study_id": 81161, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to assess the prevalence of off-label prescriptions of psychotropic drugs, including Melatonin, in children and adolescents at psychiatric outpatient clinics in Denmark.", "results_summary": "Melatonin was the most prescribed off-label psychotropic drug (106 prescriptions), with all prescriptions classified as off-label primarily due to age and indication of treatment. The study highlights the common off-label use of psychotropic drugs in children, excluding ADHD medications.", "population_specificity": "Children and adolescents attending psychiatric outpatient clinics in Denmark.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:20.458005+00:00"}
{"study_id": 81163, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the mechanisms by which melatonin protects against mitochondrial dysfunction and related disorders.", "results_summary": "Melatonin was found to prevent mitochondrial dysfunction by preserving cardiolipin integrity, thereby protecting mitochondrial bioenergetic function and reducing oxidative damage. The study suggests melatonin's potential therapeutic benefits in conditions involving mitochondrial impairment.", "population_specificity": "Not specified (general review of mechanisms)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:23.077309+00:00"}
{"study_id": 81162, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to highlight melatonin's potential as a therapeutic agent for preventing and treating diseases related to oxidative stress and physiological dysregulation.", "results_summary": "The study found that melatonin and its metabolites act as effective free-radical scavengers and broad-spectrum antioxidants, with roles in regulating circadian rhythm and immune functions. It suggests melatonin could be valuable in managing conditions like cancer, neurodegenerative disorders, and inflammatory diseases.", "population_specificity": "Not specified (general discussion of melatonin's effects).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:23.463562+00:00"}
{"study_id": 81165, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the absolute bioavailability, pharmacokinetics, safety, and tolerability of tasimelteon administered orally and intravenously in healthy volunteers.", "results_summary": "The study found tasimelteon had an absolute bioavailability of 38%, with similar elimination half-lives for oral and IV routes. Metabolite exposure ratios suggested presystemic metabolism, and the drug was well tolerated with only mild adverse events reported.", "population_specificity": "14 healthy volunteers", "effective_dosage": "20-mg capsule (oral) or 2 mg IV infusion over 30 minutes", "study_duration": "Single-dose administration with a 5 \u00b1 2-day washout period between treatments", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:25.324815+00:00"}
{"study_id": 81166, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to analyze CYP1B1's role in metabolism, including its involvement with melatonin, and its potential as a universal cancer marker and diagnostic tool.", "results_summary": "The abstract does not provide specific findings about melatonin's effects but highlights CYP1B1's involvement in melatonin metabolism and its broader implications in disease mechanisms.", "population_specificity": "Not specified (general molecular biology focus)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:27.105437+00:00"}
{"study_id": 81158, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review alternative therapies, including Melatonin, for indomethacin-responsive headaches in patients intolerant to indomethacin.", "results_summary": "Melatonin was noted as one of several alternative treatments effective in case reports and series for indomethacin-responsive headaches, though specific efficacy details were not provided.", "population_specificity": "Patients with indomethacin-responsive headaches (e.g., paroxysmal hemicrania, hemicrania continua) intolerant to indomethacin.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:27.481668+00:00"}
{"study_id": 81167, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 65, "study_goal": "The researchers aimed to determine whether sleep-promoting interventions, including melatonin, could increase sleep time in neurologic ICU patients.", "results_summary": "Sleep quantification was limited due to unscorable recordings in most patients. For those with scorable sleep, total sleep time was normal but fragmented, with reduced slow-wave and REM sleep. Clinical outcomes did not differ between intervention and control groups.", "population_specificity": "Adult patients in a neurologic ICU undergoing continuous EEG for clinical purposes.", "effective_dosage": "Not specified", "study_duration": "3 days or until EEG was stopped", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:28.070588+00:00"}
{"study_id": 81168, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate melatonin's effectiveness in reducing mercury-induced genotoxicity in peripheral blood lymphocytes compared to other antioxidants.", "results_summary": "Melatonin effectively negated mercury-induced genotoxic endpoints, showing the highest antimutagenic activity among the tested compounds (melatonin > curcumin > andrographolide) and improved cell cycle kinetics.", "population_specificity": "Peripheral blood lymphocytes (in vitro)", "effective_dosage": "0.2 mM", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:30.634023+00:00"}
{"study_id": 81169, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether melatonin supplementation could modify the regulation of hemostasis in tetraplegic patients by examining its effects on various hemostatic markers.", "results_summary": "The study found differences in circadian variation of hemostatic markers between tetraplegic and able-bodied subjects, but melatonin supplementation had no impact on these differences, suggesting minimal or no role of melatonin in hemostasis regulation in tetraplegia.", "population_specificity": "Six subjects with long-standing complete tetraplegia and six able-bodied men.", "effective_dosage": "2 mg of melatonin given 4 days before sampling.", "study_duration": "4 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:31.653336+00:00"}
{"study_id": 81171, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of melatonin therapy for improving sleep disturbances and cognitive function in patients with dementia.", "results_summary": "Melatonin therapy prolonged total sleep time by 24.36 minutes and marginally improved sleep efficacy, particularly with interventions lasting more than 4 weeks, but did not significantly impact cognitive function. No severe adverse events were reported.", "population_specificity": "Patients with dementia experiencing sleep disturbances.", "effective_dosage": "Not specified", "study_duration": "More than 4 weeks for stronger effects", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:34.189653+00:00"}
{"study_id": 81170, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the role of immune-inflammatory pathways, oxidative and nitrosative stress, and TRYCATs in bipolar disorder, including their impact on melatonin synthesis.", "results_summary": "The study highlights that pro-inflammatory cytokines drive tryptophan away from serotonin and melatonin synthesis, redirecting it down the TRYCAT pathway, which may contribute to the biological underpinnings of bipolar disorder.", "population_specificity": "Individuals with bipolar disorder (BD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:34.196232+00:00"}
{"study_id": 81164, "supplement_id": 1328, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the safety and efficacy of tasimelteon, a melatonin receptor agonist, for treating non-24-hour sleep-wake disorder in blind individuals.", "results_summary": "Tasimelteon demonstrated efficacy in reducing nighttime wakefulness and daytime napping, with a higher proportion of individuals entrained to a 24-hour cycle compared to placebo. Safety assessments indicated it was well tolerated, with common adverse events including headache, elevated alanine aminotransferase, and unusual dreams.", "population_specificity": "Totally blind individuals diagnosed with non-24-hour sleep-wake disorder.", "effective_dosage": "20 mg once daily.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:35.346343+00:00"}
{"study_id": 81172, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to analyze the role of in vitro administered melatonin on the immune response of peripheral leukocytes from SLE patients and healthy controls, focusing on cytokine production, Treg cells, and BAFF expression.", "results_summary": "Melatonin decreased IL-5 production and influenced IL-9 production in human circulating cells. It showed anti-inflammatory effects in healthy subjects but had opposite effects in SLE patients, while increasing Treg cells and reducing BAFF overexpression in SLE cells.", "population_specificity": "20 treated SLE patients and age- and sex-matched healthy controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:35.984697+00:00"}
{"study_id": 81173, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate melatonin's potential utility in managing Ebola virus infection by enhancing immune responses and inhibiting viral replication.", "results_summary": "Melatonin was found to increase NK cell cytotoxicity and heme oxygenase-1 (HO-1), which may inhibit Ebola virus replication. It also showed protective effects against septic shock and hemorrhage by reducing pro-inflammatory cytokines.", "population_specificity": "Not specified (theoretical application for Ebola virus infection management).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:36.029558+00:00"}
{"study_id": 81174, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the clinical effectiveness of melatonin in treating tinnitus by reviewing existing studies.", "results_summary": "The review found mixed results, with methodological weaknesses in the included studies, and concluded that melatonin's effectiveness for tinnitus could not be confirmed, though it may improve sleep disturbances related to tinnitus.", "population_specificity": "Individuals with tinnitus (specific demographics not detailed).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:37.833295+00:00"}
{"study_id": 81175, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compile literature supporting melatonin's neuroprotective role in traumatic brain injury (TBI) and spinal cord injury (SCI).", "results_summary": "The abstract highlights melatonin's antioxidative, antiapoptotic, neuroprotective, and anti-inflammatory properties, demonstrating its therapeutic potential in mitigating CNS injuries like TBI and SCI. Multiple studies support its effectiveness as a neuroprotective agent in neurodegenerative diseases.", "population_specificity": "Individuals with traumatic brain injury (TBI) or spinal cord injury (SCI).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:39.565601+00:00"}
{"study_id": 81177, "supplement_id": 1328, "safety_score": "75", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy and safety of melatonin as an analgesic and sedative agent in children, particularly in diagnostic and surgical procedures.", "results_summary": "The study found that melatonin has potential as an antinociceptive and sedative agent, but its effectiveness remains controversial, with incomplete data supporting its use as an alternative to midazolam in premedication.", "population_specificity": "Children undergoing diagnostic procedures (e.g., MRI, auditory brainstem response tests, EEG) or surgery.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:42.294199+00:00"}
{"study_id": 81178, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether cataract surgery improves circadian misalignment and related health outcomes, including depressive symptoms, sleep quality, and metabolic markers, potentially involving melatonin regulation.", "results_summary": "The abstract does not report specific results regarding melatonin's effects, as the study is described as a planned randomized controlled trial without outcome data.", "population_specificity": "Patients aged 60+ with grade 2 or higher nuclear cataracts, excluding those with major depression or severe ocular comorbidities.", "effective_dosage": "Not available", "study_duration": "3 months post-surgery (intervention group) or post-baseline (control group)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:43.765161+00:00"}
{"study_id": 81179, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore how interactions between the TRYCAT and melatoninergic pathways contribute to Alzheimer's disease (AD) pathology and treatment implications.", "results_summary": "The study found that decreased melatonin synthesis due to TRYCAT pathway activation impacts AD progression by altering immune activity and trophic support, linking these pathways to AD's etiology and treatment.", "population_specificity": "Alzheimer's disease patients, with a focus on those with associated depression.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:43.978452+00:00"}
{"study_id": 81176, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review patents and applications (2012-2014) involving melatonin or its synthetic analogues for treating or preventing pathological conditions, focusing on safety, efficacy, and emerging trends.", "results_summary": "Melatonin is considered safe and effective for diverse diseases, with recent patents highlighting co-administration with other drugs to enhance efficacy and reduce side-effects. However, further evidence is needed for hybrid ligands, and new melatonin analogues have declined, primarily targeting hypnotic or antioxidant uses.", "population_specificity": "Not specified (patent review, not a clinical study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "Co-administration with other drugs (e.g., tamoxifen, tacrine) noted to improve efficacy and reduce side-effects.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:44.052100+00:00"}
{"study_id": 81180, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore melatonin as an indirect therapeutic option for influencing BDNF levels to address central sensitization in chronic pain disorders.", "results_summary": "The abstract mentions melatonin as a potential indirect method to influence BDNF levels, but specific results regarding its efficacy are not detailed. It is grouped with other therapies like exercise and anti-inflammatory drugs.", "population_specificity": "Chronic pain patients, including those with neuropathic pain, fibromyalgia, whiplash, headache, and other conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:44.115385+00:00"}
{"study_id": 81181, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize the beneficial effects of melatonin, including its antioxidant properties and potential therapeutic roles in various diseases.", "results_summary": "Melatonin and its metabolites act as antioxidants, scavenging free radicals and enhancing antioxidant enzyme activity, with potential benefits in treating cancer, neurodegenerative diseases, epilepsy, diabetes, and obesity. Nightshift workers exhibit lower melatonin levels linked to increased disease risk, while blind individuals have higher levels associated with disease protection.", "population_specificity": "General population, nightshift workers, and blind individuals.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:46.065913+00:00"}
{"study_id": 81182, "supplement_id": 1328, "safety_score": "80", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine whether melatonin, in combination with chemotherapy, improves health-related quality of life (HRQoL) and survival while reducing DNA damage in advanced NSCLC patients.", "results_summary": "Melatonin showed a slight but significant improvement in social well-being (HRQoL) but did not significantly affect survival or adverse events. It demonstrated a protective effect against DNA damage in healthy cells compared to placebo.", "population_specificity": "Advanced Non-small cell lung cancer (NSCLC) patients.", "effective_dosage": "10 mg or 20 mg of melatonin.", "study_duration": "Assessments were made at baseline, 2, 3, and 7 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:48.912422+00:00"}
{"study_id": 81183, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of circadian disruption, including abnormal melatonin profiles, in alcohol-induced gut leakiness and liver pathology.", "results_summary": "The study found that human alcoholics exhibit abnormal melatonin profiles indicative of circadian disruption, which may contribute to gut leakiness and exacerbate alcohol-induced liver disease.", "population_specificity": "Human alcoholics and mouse models (Clock(\u039419) mice).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:49.495205+00:00"}
{"study_id": 81184, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the potential benefits of melatonin as part of a multifaceted approach for managing pediatric post-traumatic headaches.", "results_summary": "The study suggests that melatonin, along with other nutraceuticals, may be useful in treating post-traumatic headaches in children, though no specific efficacy data or outcomes for melatonin are provided.", "population_specificity": "Children with post-traumatic headaches following mild traumatic brain injury.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:51.589808+00:00"}
{"study_id": 81187, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential of melatonin, combined with stem cells from adipose tissue, as a novel approach for brown adipose tissue regeneration to treat metabolic disorders related to obesity.", "results_summary": "The abstract suggests that melatonin, when combined with stem cells, may have potential for treating metabolic disorders by activating and regenerating brown adipose tissue, based on animal studies. However, specific human efficacy data is not provided.", "population_specificity": "Animal models (not specified further)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:52.242549+00:00"}
{"study_id": 81185, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential of melatonin as a treatment for REM sleep behavior disorder (RBD) compared to clonazepam, focusing on safety, efficacy, and tolerability.", "results_summary": "Melatonin was found to reduce clinical behavioral outcomes and muscle tonicity during REM sleep in RBD patients, with a favorable safety and tolerability profile compared to clonazepam. The abstract suggests melatonin may be a viable alternative, especially for elderly patients on multiple medications.", "population_specificity": "Individuals with REM sleep behavior disorder (RBD), particularly elderly patients receiving polypharmacy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Limited potential for drug-drug interactions mentioned, especially relevant for elderly patients on polypharmacy.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:53.266195+00:00"}
{"study_id": 81186, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the pharmacokinetics of tasimelteon (a dual melatonin receptor agonist) in subjects with hepatic or renal impairment compared to healthy controls.", "results_summary": "Tasimelteon exposure increased approximately 2-fold in subjects with mild or moderate hepatic impairment, but no clinically relevant changes were observed in severe renal impairment. No safety concerns were identified, and no dose adjustments were deemed necessary for these populations.", "population_specificity": "Subjects with mild or moderate hepatic impairment, severe renal impairment (including dialysis patients), and healthy controls.", "effective_dosage": "Single 20 mg dose.", "study_duration": "Single administration (no long-term intervention).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:54.261536+00:00"}
{"study_id": 81188, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether tasimelteon, a melatonin agonist, could improve sleep and reset circadian rhythms in individuals with non-24 sleep-wake syndrome.", "results_summary": "The study found that tasimelteon effectively improved sleep and reset circadian sleep-wake clocks in patients with non-24 sleep-wake syndrome.", "population_specificity": "Individuals with total blindness suffering from non-24 sleep-wake syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:54.600292+00:00"}
{"study_id": 81189, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not specify a research goal regarding Melatonin.", "results_summary": "The abstract mentions that Melatonin is considered off-label for treating delirium in dementia but does not provide specific findings on its effects.", "population_specificity": "Patients with dementia experiencing delirium.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:55.183923+00:00"}
{"study_id": 81191, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to examine the effect of melatonin on clinical, biochemical, neurophysiological, and radiological outcomes in neonates with hypoxic-ischemic encephalopathy (HIE).", "results_summary": "The melatonin/hypothermia group showed increased melatonin levels, reduced nitric oxide, fewer seizures, less white matter abnormalities on MRI, and improved survival without neurological or developmental abnormalities at 6 months compared to the hypothermia-only group.", "population_specificity": "Term neonates with hypoxic-ischemic encephalopathy (HIE) and healthy controls.", "effective_dosage": "10 mg/kg daily, administered enterally in five doses.", "study_duration": "Five days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:58.060672+00:00"}
{"study_id": 81193, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether melatonin could reduce metabolic side-effects (e.g., cholesterol, blood pressure) caused by olanzapine in adolescents with bipolar disorder.", "results_summary": "Melatonin significantly inhibited the rise in total cholesterol and slowed the increase in systolic blood pressure compared to placebo. It also showed a trend (though not statistically significant) in reducing fasting blood sugar and triglyceride levels, particularly in boys.", "population_specificity": "11-17 year-old outpatients diagnosed with bipolar disorder.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "Administered alongside olanzapine and lithium carbonate.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:00.171672+00:00"}
{"study_id": 81192, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether melatonin, alone or combined with growth hormone (GH), could counteract oxidative stress, apoptosis, and inflammation in the aging heart using a senescence-accelerated mouse model.", "results_summary": "Melatonin treatment prevented age-dependent cardiac alterations in senescence-accelerated prone mice, reducing oxidative stress, inflammation, and apoptosis markers while increasing anti-inflammatory and antiapoptotic markers. Combined administration with GH showed additive benefits compared to either hormone alone.", "population_specificity": "Senescence-accelerated prone mice (10-month-old) compared to 2-month-old controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:00.305613+00:00"}
{"study_id": 81194, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy and safety of melatonin versus midazolam for sedation induction in children undergoing EEG.", "results_summary": "Melatonin was significantly more effective than midazolam in achieving adequate sedation (73.3% vs. 36.7%) with no significant difference in side effects. Transient agitation was noted in 6.6% of the midazolam group.", "population_specificity": "Children aged 1-8 years referred for EEG in a hospital setting.", "effective_dosage": "0.3 mg/kg melatonin administered orally.", "study_duration": "Single administration for EEG procedure.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:01.143365+00:00"}
{"study_id": 81195, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to assess the anti-inflammatory, analgesic, and osteogenic early effects of melatonin on post-extraction sockets in patients undergoing third molar extraction.", "results_summary": "The study found no significant differences in interleukin-6 concentration or bone density between melatonin and placebo groups, with nitrotyrosine levels below detectability.", "population_specificity": "Patients requiring extraction of both lower third molars (n=10).", "effective_dosage": "3 mg of local melatonin applied post-extraction.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:01.954394+00:00"}
{"study_id": 81197, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review and summarize current literature on melatonin's role in gamete biology and its potential benefits for improving pregnancy rates in IVF.", "results_summary": "The abstract suggests melatonin may improve oocyte and embryo quality in IVF, with some clinical studies indicating better pregnancy rates. However, it calls for more well-designed trials to confirm these findings.", "population_specificity": "Individuals undergoing in-vitro fertilization (IVF).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:02.435722+00:00"}
{"study_id": 81196, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the robustness of translating findings from animal studies on circadian rhythms to effective jet lag treatments in humans, particularly focusing on melatonin.", "results_summary": "The study found weak translational links between animal models and human jet lag treatments, with limited and inconsistent evidence from randomized controlled trials on melatonin. Effect sizes for melatonin studies decreased over time, and only a small number of trials were available for meta-analysis.", "population_specificity": "Human travelers (cabin crew, pilots, and general travelers) and animal models (rodents).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:03.836494+00:00"}
{"study_id": 81198, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore melatonin's potential in preventing programmed hypertension through epigenetic regulation in the kidneys during maternal and perinatal phases.", "results_summary": "The review highlights melatonin's role in epigenetic regulation and its beneficial effects on programmed hypertension, supported by whole-genome RNA sequencing analysis of maternal melatonin therapy across different developmental windows in offspring kidneys.", "population_specificity": "Maternal and perinatal phases, focusing on offspring kidney development.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:05.855166+00:00"}
{"study_id": 81200, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to explore melatonin's role in the circadian system, including its effects on the SCN master clock and peripheral oscillators, as well as its potential clinical applications.", "results_summary": "Melatonin acts as a temporal cue distributor from the SCN to tissues with melatonin receptors, driving or synchronizing daily rhythms in target tissues. Exogenous melatonin can synchronize the SCN clock, and melatonin agonists show promise for improving circadian timing.", "population_specificity": "Not specified (general mammalian physiology, with implications for humans)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:08.613303+00:00"}
{"study_id": 81199, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to investigate melatonin's receptor-dependent and -independent mechanisms in blood pressure regulation and its potential as an antihypertensive agent.", "results_summary": "Melatonin demonstrated antihypertensive effects through receptor-mediated actions (MT1 and MT2) and receptor-independent mechanisms like ROS scavenging and mitochondrial efficiency improvement. It also modulated the sympathetic-parasympathetic balance in the CNS, suggesting protective effects against hypertension.", "population_specificity": "Experimental and clinical hypertension cases (specific population not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:08.650360+00:00"}
{"study_id": 81201, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine melatonin's role in protecting human skin against UVR-induced damage, including its mechanisms of action and therapeutic potential.", "results_summary": "Melatonin demonstrated strong protective effects against UVR-induced skin damage, including DNA repair, primarily through receptor-independent mechanisms or possible nuclear receptor activation. It was proposed as a potent anti-oxidative defense system with clinical applications in UVR-related pathologies like carcinogenesis and skin aging.", "population_specificity": "Human skin (not specified if in vivo or in vitro)", "effective_dosage": "High (pharmacological) concentrations mentioned, but exact dosage not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:09.119261+00:00"}
{"study_id": 81203, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential utility of melatonin for treating Ebola virus infection, focusing on its ability to address pathological changes like endothelial disruption and disseminated intravascular coagulation.", "results_summary": "The study suggests melatonin may be effective for Ebola treatment by targeting key pathological changes and draws parallels to its successful use in sepsis. It highlights melatonin's high safety profile, availability, and ease of administration as advantages for large-scale outbreaks.", "population_specificity": "Individuals infected with the Ebola virus.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:10.059393+00:00"}
{"study_id": 81202, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential benefits of melatonin in mitigating chronic kidney disease (CKD) progression by examining its anti-inflammatory, anti-apoptotic, and antioxidant properties.", "results_summary": "Melatonin demonstrated protective effects in animal models of CKD by reducing oxidative stress, inflammation, and apoptosis, leading to decreased proteinuria and fibrosis. In humans, it improved sleep disturbances and oxidative burden in hemodialyzed patients.", "population_specificity": "Animal models (hypertension, diabetes, nephrotoxicity) and hemodialyzed patients with CKD.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:10.533014+00:00"}
{"study_id": 81204, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine baseline daily variations and nocturnal excretion of melatonin in ADHD subtypes and assess the effect of chronic methylphenidate administration on melatonin levels and symptomatology.", "results_summary": "Melatonin levels were higher in hyperactive-impulsive/conduct disordered ADHD children, unaffected by depressive symptoms. Methylphenidate improved comorbidity without altering serum melatonin but reduced urinary melatonin metabolite excretion in both ADHD subtypes.", "population_specificity": "136 children with ADHD (DSM-IV-TR criteria), subdivided by ADHD subtypes and depressive symptoms.", "effective_dosage": "Not specified", "study_duration": "4.61 \u00b1 2.29 months", "interactions": "Methylphenidate (decreased urinary melatonin metabolite excretion)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:12.452284+00:00"}
{"study_id": 81206, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare melatonin and synthetic melatoninergic agonists regarding their properties, therapeutic limits, and effectiveness in treating circadian rhythm disorders and depression.", "results_summary": "Melatoninergic agonists effectively entrain circadian rhythms when chronobiological rules are followed, aiding in treating dysphased rhythms, sleep disorders, and depression linked to circadian dysfunction. However, sleep maintenance is poorly supported, and genetic, epigenetic, or neurodegenerative factors may limit treatment success.", "population_specificity": "Not specified (general discussion of melatoninergic agonists)", "effective_dosage": "Low doses of immediate-release melatonin mentioned as sufficient for sleep onset, but specifics not provided.", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:14.172063+00:00"}
{"study_id": 81205, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether abnormalities in the melatonin signaling pathway, particularly involving the MT2 receptor, contribute to abnormal skeletal growth in adolescent idiopathic scoliosis (AIS) patients.", "results_summary": "Melatonin significantly reduced cell viability and mRNA expression of COLX and ALP in control growth plate chondrocytes (GPCs) but had no effect on GPCs from AIS patients, suggesting a functional abnormality in the melatonin signaling pathway in AIS. The selective MT2 antagonist 4-P-PDOT blocked melatonin's effects in control GPCs.", "population_specificity": "Twenty AIS patients and ten normal control subjects.", "effective_dosage": "1 nM, 100 nM, and 10 \u00b5M melatonin.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:14.535454+00:00"}
{"study_id": 81207, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to summarize how melatonin regulates epigenetic processes in neurons and its potential role in brain aging and anti-aging mechanisms.", "results_summary": "The study highlights melatonin's association with key signaling pathways (IGF-1, FoxOs, sirtuins, mTOR) involved in energy metabolism, autophagy, and circadian rhythms, suggesting its potential in regulating brain aging and promoting healthy lifespan.", "population_specificity": "Not specified (review of existing literature).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:16.284742+00:00"}
{"study_id": 81209, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the cardioprotective effects of melatonin against ischemia-reperfusion injury and summarize its downstream signaling pathways.", "results_summary": "Melatonin preserved cardiomyocyte microstructure, reduced myocardial ischemia-reperfusion injury, and activated protective signaling pathways such as JAK2/STAT3, nitric oxide-synthase, and Nrf2. The findings suggest potential clinical applications for melatonin in ischemic heart diseases.", "population_specificity": "In vitro, animal, and human studies (not specified in detail).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:17.094453+00:00"}
{"study_id": 81208, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to explore melatonin's potential protective mechanisms against doxorubicin-induced cardiotoxicity, focusing on mitochondrial function, free radical generation, and cell death.", "results_summary": "The abstract suggests melatonin has antioxidant properties and may support mitochondrial homeostasis, but the exact protective mechanisms against doxorubicin-induced cardiotoxicity remain unclear. Some mitochondrial parameters, such as mitophagy and fission/fusion, lack sufficient evidence regarding melatonin's role.", "population_specificity": "Not specified (general focus on potential applications for cancer survivors experiencing doxorubicin-induced cardiotoxicity).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:18.134112+00:00"}
{"study_id": 81211, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a sequence of light flashes delivered during sleep could shift circadian timing without disrupting sleep.", "results_summary": "Subjects exposed to light flashes during sleep exhibited a significant delay in circadian melatonin rhythm compared to controls, without major alterations to sleep quality or duration. The flashes penetrated the eyelids and evoked EEG responses, confirming their biological effect.", "population_specificity": "Healthy volunteers", "effective_dosage": "2-msec light flashes every 30 sec for 1 hour (total 0.24 sec of light)", "study_duration": "2-night laboratory stay (intervention administered for 1 hour each night)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:18.542164+00:00"}
{"study_id": 81210, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the role of melatonin in the circadian rhythm of inflammatory markers and symptoms in rheumatoid arthritis (RA) patients, and assess the efficacy of chronotherapy with glucocorticoids.", "results_summary": "The study found that melatonin, along with other pro-inflammatory hormones, contributes to nocturnal inflammation in RA patients. Chronotherapy with nighttime glucocorticoids, including melatonin-related timing, significantly improved morning stiffness and reduced IL-6 levels compared to conventional daytime treatment.", "population_specificity": "Early rheumatoid arthritis (RA) patients.", "effective_dosage": "Not specified for melatonin; glucocorticoid dosage mentioned as low-dose, long-term prednisone (night-release formulations).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:18.543472+00:00"}
{"study_id": 81212, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to assess the therapeutic and prophylactic effects of melatonin in adult patients with depression or depressive symptoms.", "results_summary": "Most studies showed no significant difference between melatonin and placebo in improving depression scores, though one study found a prophylactic effect and another a treatment effect. Meta-analyses did not show any significant effect of melatonin.", "population_specificity": "Adult patients with or without depression at inclusion.", "effective_dosage": "0.5-6 mg daily", "study_duration": "2 weeks to 3.5 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:19.294970+00:00"}
{"study_id": 81213, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of Melatonin in treating chronic insomnia and core ADHD symptoms in children with ADHD.", "results_summary": "Melatonin was found to be effective in treating chronic insomnia in children with ADHD but had minimal effects on reducing core ADHD symptoms. The abstract notes that many natural supplements, including Melatonin, are widely used despite minimal evidence of efficacy and possible side effects.", "population_specificity": "Children with ADHD", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:21.552626+00:00"}
{"study_id": 81214, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to investigate whether melatonin acts as a proteasome inhibitor and its potential synergistic effects with proteasome inhibitors in cancer treatment.", "results_summary": "The study found that melatonin shares molecular targets with the proteasome inhibitor bortezomib, exhibits selective pro-apoptotic effects in cancer cells, and enhances TRAIL-induced apoptosis in human glioma cells. Direct evidence of melatonin inhibiting the proteasome was observed in human renal cancer cells.", "population_specificity": "Human renal cancer cells and human glioma cells (in vitro study).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:22.562517+00:00"}
{"study_id": 81215, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of circadian rhythm disturbances, including melatonin dysregulation, in bipolar disorder and its implications for therapeutic interventions.", "results_summary": "The study found that patients with bipolar disorder exhibit altered melatonin rhythms and persistent sleep-wake cycle disturbances, suggesting circadian pathology as a unifying model for the disorder's psychiatric and medical comorbidities.", "population_specificity": "Patients with bipolar disorder.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:22.924863+00:00"}
{"study_id": 81219, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were exploring the potential role of the serotonin-melatonin-oxidative stress-placental intersection in ASD.", "results_summary": "The abstract suggests that the serotonin-melatonin-oxidative stress-placental intersection might be a promising area for biological investigation in ASD, but no specific results about Melatonin's effects are provided.", "population_specificity": "Not specified (general ASD research context)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:25.595636+00:00"}
{"study_id": 81217, "supplement_id": 1328, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the efficacy and safety profiles of melatonin receptor agonists (ramelteon, prolonged-release melatonin, agomelatine, and tasimelteon) for treating insomnia, depression, and circadian rhythm sleep-wake disorders, as well as their effects on comorbid conditions.", "results_summary": "The study found that melatonin receptor agonists are effective for treating sleep-wake disorders and also have beneficial effects on comorbid neurological, psychiatric, cardiovascular, and metabolic conditions. The review highlights the importance of enhancing physiological sleep in comorbid conditions.", "population_specificity": "Patients with insomnia, depression, and circadian rhythm sleep-wake disorders, including those with comorbid medical conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:26.615849+00:00"}
{"study_id": 81216, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate melatonin's potential to improve metabolic disorders such as obesity, diabetes, and metabolic syndrome by examining its effects on oxidative stress, inflammation, and adipose tissue browning.", "results_summary": "Melatonin demonstrated capacity to ameliorate metabolic profiles, including reducing oxidative stress, improving glucose homeostasis, and inducing white adipose tissue browning, potentially aiding in body weight reduction. Further clinical studies are needed to confirm these effects at pharmacological doses.", "population_specificity": "Experimental animal models (specific species not mentioned) and implied relevance to humans with metabolic disorders.", "effective_dosage": "Pharmacological doses between 5 and 20 mg/kg body weight in animal models; clinical studies used 0.050\u20130.16 mg/kg body weight.", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:27.052700+00:00"}
{"study_id": 81218, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "To examine the efficacy of tasimelteon for treating non-24-hour sleep-wake disorder by assessing its impact on sleep efficiency, circadian rhythm shifts, and sleep maintenance.", "results_summary": "Tasimelteon demonstrated significant improvements in circadian rhythm entrainment, sleep initiation, and maintenance compared to placebo across multiple trials, with statistically significant results (P \u2264 0.0055). However, the cost of tasimelteon was noted as a limiting factor.", "population_specificity": "Patients with non-24-hour sleep-wake disorder, including blind men and women.", "effective_dosage": "20 mg daily (maintenance), 100 mg (phase II trial).", "study_duration": "Varied (3 days in phase II, 8 weeks in RESET trial).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:27.620059+00:00"}
{"study_id": 81220, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 30, "quality_score": 90, "study_goal": "The researchers aimed to determine whether melatonin could reduce the incidence and duration of delirium in elderly patients undergoing acute hip surgery.", "results_summary": "The study found no significant effect of melatonin on the incidence of delirium (29.6% in the melatonin group vs. 25.5% in the placebo group) or on secondary outcomes like mortality, cognitive, or functional outcomes at 3-month follow-up.", "population_specificity": "Elderly patients (mean age 84 years) scheduled for acute hip surgery, including those with cognitive impairment.", "effective_dosage": "3 mg administered in the evening for 5 consecutive days.", "study_duration": "5 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:27.854335+00:00"}
{"study_id": 81222, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of 5 mg daily melatonin supplementation over 90 days on oxidative stress markers (MDA and SOD) and quality of life in MS patients.", "results_summary": "Melatonin reduced MDA levels in interferons-beta and glatiramer acetate-treated groups, increased SOD activity in some groups, and improved psychological quality of life in interferons beta-treated patients. No significant physical quality of life changes were observed.", "population_specificity": "102 MS patients and 20 age- and sex-matched controls.", "effective_dosage": "5 mg daily", "study_duration": "90 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:30.234612+00:00"}
{"study_id": 81221, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether oral melatonin supplementation during ovarian stimulation could improve assisted reproductive technology outcomes by testing different dosages in a randomized controlled trial.", "results_summary": "The study is a proposed pilot trial and does not yet report results; it focuses on evaluating clinical pregnancy rates, oocyte/embryo quality, oxidative stress markers, and other secondary outcomes across four dosage groups.", "population_specificity": "160 infertile women undergoing IVF treatment.", "effective_dosage": "2 mg twice per day, 4 mg twice per day, and 8 mg twice per day.", "study_duration": "During ovarian stimulation (specific duration not stated).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:30.402084+00:00"}
{"study_id": 81223, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of circadian regulation in type 2 diabetes (T2DM) and propose chronotherapeutic strategies, including proper timing of food intake, as non-pharmaceutical interventions.", "results_summary": "The study suggests that circadian clock malfunction, influenced by factors like nocturnal light exposure and irregular sleep/wake schedules, may contribute to T2DM. Strengthening circadian clock function and timing food intake could stabilize glucose homeostasis, offering a potential chronotherapeutic approach.", "population_specificity": "General discussion on circadian regulation and T2DM, no specific population studied.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:31.429292+00:00"}
{"study_id": 81226, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential efficacy of melatonin in treating endometriosis-associated pelvic pain based on animal studies.", "results_summary": "Melatonin was found to be efficacious in animal studies for endometriosis-associated pain, but it has not yet been tested in clinical studies.", "population_specificity": "Animal models (not specified further).", "effective_dosage": "Not available.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:33.281178+00:00"}
{"study_id": 81224, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to compare the treatment efficacy of various drug classes, including melatonin receptor agonists, for primary insomnia using objective and subjective outcome measures.", "results_summary": "The study found small-to-moderate, significant effects for both objective and subjective outcomes, with benzodiazepine receptor agonists and classical benzodiazepines showing higher efficacy than antidepressants, but melatonin receptor agonists were not specifically highlighted in the results.", "population_specificity": "3,820 participants with primary insomnia.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:33.895540+00:00"}
{"study_id": 81225, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to examine potential interactions between melatonin supplementation and hormone replacement therapy (HRT) in postmenopausal women.", "results_summary": "The study found that melatonin supplementation, when coupled with estrogen therapy, may lead to increased serum levels of dietary supplements, suggesting a potential beneficial interaction. However, the abstract does not provide detailed efficacy data on melatonin's specific effects.", "population_specificity": "Postmenopausal women using hormone replacement therapy (HRT).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "Mentioned interaction with estrogen therapy, potentially increasing serum levels of melatonin.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:33.995601+00:00"}
{"study_id": 81227, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate melatonin's neuroprotective effects, focusing on its antioxidative properties, mitochondrial function enhancement, and antiapoptotic attributes in neurological diseases.", "results_summary": "Melatonin demonstrated potent neuroprotective action in experimental models and clinical studies, with benefits including free radical scavenging, antioxidant effects, antiapoptotic activity, and improved mitochondrial function. However, it did not entirely prevent disease, suggesting its potential use in combination therapies.", "population_specificity": "Experimental models and clinical studies (specific populations not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:35.611861+00:00"}
{"study_id": 81228, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effect of melatonin on sleep quality and circadian rhythms in ICU patients using polysomnography, the gold standard for sleep assessment.", "results_summary": "The study assessed melatonin's impact on sleep quality, anxiety, delirium-free days, ventilation-free days, antibiotic-free days, ICU length of stay, and mortality, but specific results were not detailed in the abstract. Secondary outcomes included biochemical markers of stress and inflammation.", "population_specificity": "Critically ill patients in intensive care units (ICU).", "effective_dosage": "3 mg of oral melatonin administered at 9:00 pm.", "study_duration": "Four consecutive days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:35.921378+00:00"}
{"study_id": 81229, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the effects of melatonin supplementation on inflammatory and oxidative stress parameters in obese women.", "results_summary": "Melatonin supplementation significantly reduced serum TNF-\u03b1, IL-6, hsCRP, and MDA levels in obese women, while TAC levels increased slightly. No significant improvements were observed in the placebo group.", "population_specificity": "44 obese women (22 in melatonin group, 22 in placebo group).", "effective_dosage": "6 mg daily.", "study_duration": "40 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:38.124265+00:00"}
{"study_id": 81231, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate melatonin's role in neurodegenerative processes, specifically in multiple sclerosis, Huntington's disease, and cerebral ischemia, and its potential therapeutic use.", "results_summary": "Melatonin demonstrated antioxidant and anti-inflammatory properties, reducing cell damage linked to oxidative stress and inflammation in neurodegenerative disorders. Changes in melatonin levels were observed in these diseases, suggesting its involvement in their pathogenic mechanisms and therapeutic potential.", "population_specificity": "Individuals with neurodegenerative diseases (multiple sclerosis, Huntington's disease, cerebral ischemia).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:39.205912+00:00"}
{"study_id": 81230, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the therapeutic effects of melatonin as a component of animal biles in traditional Chinese medicine, focusing on its potential benefits for liver function, anti-inflammatory, anti-oxidant, and other health effects.", "results_summary": "The study found that melatonin, along with other bile components, exhibited salutary effects such as improving liver function, anti-inflammatory, anti-oxidant, sedative, and other therapeutic properties. The analysis was based on historical ethnopharmacological data and modern chemical identification techniques.", "population_specificity": "Not specified (general ethnopharmacological and chemical analysis)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:39.208652+00:00"}
{"study_id": 81234, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether combining intratympanic corticosteroid with melatonin could reduce tinnitus in patients with unilateral acute idiopathic tinnitus developed within 3 months.", "results_summary": "Both melatonin alone and melatonin combined with intratympanic dexamethasone significantly improved tinnitus outcomes, but the combination group showed statistically superior improvements in loudness, awareness, handicap, sleep quality, and depression scores.", "population_specificity": "Patients with unilateral acute idiopathic tinnitus developed within 3 months.", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:41.445879+00:00"}
{"study_id": 81232, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the mechanism of action, pharmacokinetics, clinical efficacy, safety, and tolerability of tasimelteon, a melatonin-receptor agonist, for treating non-24-hour sleep-wake disorder.", "results_summary": "The study found that tasimelteon demonstrated clinical efficacy in treating non-24-hour sleep-wake disorder, with a focus on its pharmacokinetic properties and safety profile. Information was gathered from multiple sources, including clinical trials and regulatory documents.", "population_specificity": "Patients with non-24-hour sleep-wake disorder.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:42.197209+00:00"}
{"study_id": 81235, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the sleep and circadian effects of drugs commonly used to treat headache disorders, including potential impacts on sleep physiology.", "results_summary": "The study concluded that headache medications may significantly affect sleep physiology, but further research is needed to characterize these effects and optimize their use to avoid detrimental sleep complaints or leverage beneficial properties.", "population_specificity": "Humans with headache disorders (specific population not detailed in abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:42.875586+00:00"}
{"study_id": 81237, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the pharmacokinetic profile and bioavailability of a new melatonin soft gel capsule form with commercially available melatonin powder.", "results_summary": "The melatonin soft gel capsule showed similar pharmacokinetic parameters to higher doses of melatonin powder but with improved bioavailability, suggesting better absorption even at reduced doses.", "population_specificity": "60 healthy volunteers", "effective_dosage": "1 mg and 3 mg of melatonin powder, 1 mg of melatonin in soft gel capsules", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:45.038678+00:00"}
{"study_id": 81236, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether melatonin alone or combined with amitriptyline improves the endogenous pain-modulating system and clinical symptoms (pain, pain threshold, sleep quality) in fibromyalgia patients compared to amitriptyline alone.", "results_summary": "Melatonin alone or combined with amitriptyline significantly reduced pain (VAS scores) and improved the inhibitory pain-modulating system (NPS reduction during CPM-TASK) compared to amitriptyline alone. The combination showed marginal additional benefits in Fibromyalgia Impact Questionnaire (FIQ) and pressure pain threshold (PPT) improvements.", "population_specificity": "63 females aged 18-65 with fibromyalgia.", "effective_dosage": "10 mg melatonin at bedtime, alone or with 25 mg amitriptyline.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:45.348072+00:00"}
{"study_id": 81239, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether filtering short wavelengths from nocturnal lighting could mitigate circadian misalignment and its associated health effects, including alterations in melatonin secretion.", "results_summary": "The study found that filtering short wavelengths attenuated disruptions in melatonin secretion and improved mood, cognitive performance, sleep duration, and quality in shift workers. The effects were observed in both laboratory and field-based settings.", "population_specificity": "Shift workers (both animal and clinical models).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:47.302094+00:00"}
{"study_id": 81238, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize the protective effects of melatonin on hepatic ischemia/reperfusion injury (IRI) and evaluate its clinical application and safety.", "results_summary": "Melatonin demonstrated notable antioxidant and anti-inflammatory properties, protecting against hepatic IRI by mitigating endothelial and mitochondrial dysfunction and influencing key signaling pathways like HO-1, TLR, and JNK. The review suggests melatonin has potential as a therapeutic target for hepatic diseases.", "population_specificity": "Hepatic ischemia/reperfusion injury (IRI) models (not specified if human or animal).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:48.153723+00:00"}
{"study_id": 81241, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential of melatonin as a new therapeutic approach for viral infections.", "results_summary": "The abstract mentions melatonin as part of new therapeutic approaches for viral infections, but no specific results or outcomes are detailed regarding its effectiveness.", "population_specificity": "Not specified (likely children, given the journal's focus).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:49.445161+00:00"}
{"study_id": 81242, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the role of local melatonin and NAS production in regulating central inflammation and their implications in various medical conditions.", "results_summary": "The study found that melatonin and NAS have antioxidant, anti-inflammatory, and mitochondrial-enhancing effects, with decreased production linked to various disorders. The benefits of serotonin-boosting medications are partly mediated by increasing local NAS and melatonin production in astrocytes.", "population_specificity": "Not specified (broad range of medical conditions including psychiatric, neurodegenerative, and inflammatory disorders).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:50.264862+00:00"}
{"study_id": 81244, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the neuroprotective potential of melatonin and melatonin receptor targeting as therapeutic strategies for stroke.", "results_summary": "The abstract reviews preclinical and clinical data supporting melatonin's use for stroke, suggesting it as a promising neuroprotective agent, but does not provide specific outcome metrics.", "population_specificity": "Stroke patients (preclinical and clinical data reviewed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:51.648936+00:00"}
{"study_id": 81233, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether the probiotic VSL#3 influences melatonin levels and whether this mediates improvements in IBS symptoms, psychological parameters, and pain sensitivity.", "results_summary": "VSL#3 increased morning melatonin levels in males and those with normal diurnal melatonin fluctuations, correlating with improved bowel habits, reduced symptom severity, and enhanced quality of life. The probiotic also raised rectal pain thresholds and reduced abdominal pain duration.", "population_specificity": "42 IBS patients", "effective_dosage": "Not specified", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:52.057824+00:00"}
{"study_id": 81243, "supplement_id": 1328, "safety_score": "85", "efficacy_score": null, "quality_score": 90, "study_goal": "The researchers aimed to determine if treatment with melatonin (3 mg or 10 mg) improves post-concussion syndrome symptoms in youths following mild traumatic brain injury.", "results_summary": "The study is designed as a randomized, double-blind, placebo-controlled trial, but the abstract does not report specific results regarding melatonin's effects on post-concussion syndrome symptoms.", "population_specificity": "Youths aged 13-18 with mild traumatic brain injury who were symptomatic at 30 days post-injury.", "effective_dosage": "Sublingual melatonin 3 mg and 10 mg, administered daily.", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:53.224288+00:00"}
{"study_id": 81245, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize melatonin's role and circadian rhythms in optimizing female reproductive physiology, particularly at the peripheral level.", "results_summary": "Melatonin strengthens peripheral oscillators, protects oocytes from oxidative stress, aids fetal SCN organization, and preserves placental function. Disrupted circadian rhythms and melatonin cycles negatively impact ovarian physiology and placental function.", "population_specificity": "Female reproductive physiology (granulosa cells, cumulus oophorus, oocytes, placenta, and fetal development).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:54.736526+00:00"}
{"study_id": 81246, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore melatonin's protective effects on mitochondrial function, placental health, and its potential role in managing pre-eclampsia and other obstetric pathologies.", "results_summary": "Melatonin demonstrated strong mitochondrial protection, comparable or superior to other antioxidants, and improved cellular oxidoreduction and inflammatory states. It was highlighted as essential for trophoblastic function and development, with altered levels linked to pre-eclampsia, suggesting its potential as both a biomarker and treatment.", "population_specificity": "Pregnant individuals, particularly those with placental defects or pre-eclampsia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:56.323516+00:00"}
{"study_id": 81240, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate melatonin receptor expression in the human myometrium and its role in uterine contractility during late-term pregnancy.", "results_summary": "Melatonin enhances oxytocin-dependent signaling and contractions in the myometrium, while acute light exposure reversibly suppresses uterine contractions. These findings suggest melatonin plays a significant role in regulating uterine contractions during late-term pregnancy.", "population_specificity": "Late-term pregnant volunteers", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:57.897962+00:00"}
{"study_id": 81247, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine whether prolonged-release melatonin (PRM) improves cognitive functioning and sleep in Alzheimer's disease (AD) patients, particularly those with comorbid insomnia.", "results_summary": "PRM significantly improved cognitive performance (measured by IADL and MMSE) and sleep efficiency (measured by PSQI) in AD patients, with more pronounced benefits in those with insomnia. The treatment was well-tolerated with an adverse event profile similar to placebo.", "population_specificity": "80 patients (50.7% men, 49.3% women, average age 75.3 years) diagnosed with mild to moderate AD, with and without insomnia comorbidity.", "effective_dosage": "2 mg nightly", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:58.134734+00:00"}
{"study_id": 81248, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether corticosteroids influence melatonin release and CGRP levels in episodic cluster headache patients, potentially indicating effects on hypothalamic dysfunction and trigeminal activation.", "results_summary": "Corticosteroid administration significantly increased nocturnal melatonin metabolite (aMT6s) excretion and reduced CGRP plasma levels in cluster headache patients, correlating with decreased headache frequency. No significant changes were observed in control subjects.", "population_specificity": "Episodic cluster headache patients (n=9) and multiple sclerosis controls (n=6).", "effective_dosage": "Not specified for melatonin (study focused on corticosteroid effects).", "study_duration": "Three days of intravenous methylprednisolone followed by oral tapering with prednisone.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:58.806924+00:00"}
{"study_id": 81249, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of melatonin in preventing tenofovir disoproxil fumarate (TDF)-induced nephrotoxicity, specifically its effects on proximal tubular mitochondrial damage.", "results_summary": "Pretreatment with melatonin prevented all known histological changes in proximal tubular mitochondria induced by TDF, suggesting a protective effect against TDF-induced nephrotoxicity. However, the study notes that further human studies are needed to confirm these findings.", "population_specificity": "Not specified (preclinical evidence, likely animal or in vitro models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:37:00.235276+00:00"}
{"study_id": 81250, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential of preconditioning stem cells with melatonin to improve survival, proliferation, and migration of grafted stem cells in ischemic stroke treatment.", "results_summary": "The study suggests that melatonin, among other factors, may enhance grafted stem cell survival, proliferation, and migration to ischemic areas, potentially improving neurobehavioral outcomes in stroke models. However, specific efficacy data for melatonin alone were not detailed.", "population_specificity": "Preclinical models (likely animal studies) focusing on ischemic stroke.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:37:00.355365+00:00"}
{"study_id": 81252, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore melatonin's potential therapeutic role in obesity due to its antioxidant, anti-inflammatory, and metabolic regulatory properties.", "results_summary": "The study suggests melatonin could be beneficial in treating obesity by mitigating oxidative stress, reducing inflammation, and improving metabolic dysregulation associated with obesity. However, specific clinical outcomes or statistical results are not detailed in the abstract.", "population_specificity": "Individuals with obesity and related metabolic disorders (not further specified).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:37:01.945339+00:00"}
{"study_id": 81253, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether M-II, an active metabolite of ramelteon, contributes to the hypnotic effects of ramelteon by assessing its binding affinity, potency, and sleep-improving effects.", "results_summary": "M-II showed lower binding affinity and potency compared to ramelteon in vitro but significantly improved sleep in cats at higher doses, suggesting it may contribute to ramelteon's clinical efficacy.", "population_specificity": "Cats (in vivo), Chinese hamster ovary cells expressing human melatonin receptors (in vitro)", "effective_dosage": "Not specified (higher doses used in vivo)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:37:04.472200+00:00"}
